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Abstract 
 
 
Catalytic aerobic oxidation of phenyl hydroxycarbamate 1 and 1-hydroxy-3-phenylurea 2 using CuCl2 
and 2-ethyl-2-oxazoline in methanol gave acyl nitroso species in situ, which were trapped in nitroso-
Diels-Alder (NDA) reactions with various dienes to afford the corresponding cycloadducts in high 
yields (90-98%). Competing ene products were also present for dienes containing both alkene π-bonds 
and allylic σ-bonds, and the ene yields are higher with 1 than with 2. The use of the chiral hydroxamic 
acid, (R)-1-hydroxy-3-(1-phenylethylurea) 3 (same conditions) gave NDA cycloadducts in high yields 
(97-99%) with no ene product from 2,3-dimethyl-1,3-butadiene. NDA cycloadducts were not obtained 
from other hydroxamic acid analogues [RCONHOH (R = PhCH2 4; Ph(CH2)2 5; Ph(CH2)3 6; Ph(CH2)4 
7; Ph 8; 2-pyridyl 9; 3-pyridyl 10], with various dienes using the copper-oxidation, but were obtained 
using sodium periodate, resulting in variable NDA yields (13-51%) from hydroxamic acids 1-10 with 
cyclohexa-1,3-diene and 2,3-dimethyl-1,3-butadiene (several cycloadducts characterized by X-ray 
crystallography). The NDA and nitroso-ene reaction pathways of nitroso intermediates with dienes were 
mapped by DFT computations (B3LYP/6-31G*) which showed that the acyl nitroso species are super-
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reactive and activation energies in the NDA processes are lower than the isomerization barriers between 
some cis- and trans-butadienes. 
 
 
Introduction 
Nitroso compounds have been widely used and studied in organic chemistry for over a century, with 
Baeyer's synthesis of nitroso benzene reported in 1874.1 Since then, not only have the methods of 
synthesis improved substantially (Baeyer reacted diphenylmercury with nitroso bromide), but the range 
of nitroso species accessible and their range of reactions has increased substantially.2 Indeed, the hetero-
Diels-Alder reaction has been widely used not only to derive oxazine systems,2 but also for a wide-
range of synthetic applications,3 including asymmetric synthesis4 and recently in flow chemistry.5  
Although nitroso arenes are probably most well known as nitroso dienophiles, many of which are also 
commercially available or readily prepared, one of the most useful, and indeed, reactive classes of 
nitroso dienophiles are the acyl nitroso (or nitroso carbonyl) species.3 However, unlike their nitroso 
arene counterparts, these compounds have not been isolated or characterized, being generated in situ, 
generally by the oxidation of hydroxamic acids. The resulting acyl nitroso species are then trapped by 
suitable dienes to yield the corresponding [4+2]-cycloaddition products. As part of a program to 
develop wider applications of acyl nitroso compounds in synthetic applications, we and others,6 have 
been involved in developing cleaner in situ methods for the oxidation of hydroxamic acids, that improve 
upon the use of periodates, DMSO-based oxidants and lead(IV)-based reagents etc.7 Even though 
peroxides are less toxic, the yields depend upon the substrate, oxidant and catalyst.7 We recently 
reported the use of a Cu(II)-catalyzed, air-based, in situ hydroxamic acid oxidation reaction, as shown in 
Scheme 1,8 which was particularly clean and efficient, and related reactions have been widely used in 
synthesis.3,4,9-11 During these studies, it is clear that both the regiochemistry of nitroso-Diels-Alder 
(NDA) reactions, and often the chemoselectivity of the acyl nitroso species is not always predictable, 
and is difficult to control.8-11 As a consequence, we undertook to study systematically this reaction both 
experimentally and theoretically, in order to develop an understanding of the principles which govern 
the reactivity of acyl nitroso compounds of different types with variously substituted dienes, and herein, 
we discuss our findings. 
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Scheme 1. Reactions of N-(benzyloxycarbonyl)hydroxylamine with various dienes using the copper-
oxazoline catalyst and air system. 
 
Results and discussion 
 
Syntheses and Characterizations of Compounds 1-53 
 
The hydroxamic acids 1-12 listed in Table 1 and were prepared from reactions of hydroxylamine 
hydrochloride with appropriate chlorides, isocyanates, carboxylic acids or esters. A new compound 13 
was obtained in 13% yield from (R)-(1-isocyanatoethyl)benzene with hydroxylamine hydrochloride in 
the synthesis of (R)-1-hydroxy-3-(1-phenylethylurea) 3. 
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Table 1. Reactions of cyclohexa-1,3-diene and 2,3-dimethyl-1,3-butadiene with nitroso compounds prepared in situ from 
oxidations of hydroxamic acids, 1-10. 
 
 
Hydroxamic Acid Entry Cycloadduct from 
cyclohexa-1,3-diene 
GP1a 
Yield 
GP2b 
Yield 
GP3c 
Yield 
Entry Product(s) from 2,3-dimethyl-1,3-butadiene 
 
GP1a 
Yield 
GP2b 
Yield 
GP3c 
Yield 
 
  1 
 
 
1 
 
 14d,e 
 
 
51 
 
 
98 
 
 
- 
 
 
11 
 
    
24                                       34 
24:34 Ratio 1:0 from GP1; 6:1 from GP2 
 
 
 
47 
 
 
95 
 
 
- 
  2e 
 
2 
 15e,f 
 
49 
 
98 
 
- 
 
12 
    
25e,g                           35g 
25:35 Ratio 1:0 from GP1; 9:1 from GP2 
 
 
45 
 
90 
 
- 
  3e 
 
 
3 
 16e 
 
 
42 
 
97 
 
- 
 
13 
  26 
 
13 
 
99 
 
- 
  4 
 
 
4 
 17e 
 
 
48 
 
0 
 
61 
 
14 
  27 
 
42h 
 
0 
 
0 
  5 
 
 
5 
 18 
 
 
49 
 
0 
 
65 
 
15 
  28 
 
37h 
 
0 
 
0 
  6 
 
 
6 
 19 
 
 
32 
 
0 
 
73 
 
16 
  29 
 
40h 
 
0 
 
0 
 7 
 
 
7 
 20 
 
 
38 
 
0 
 
78 
 
17 
  30 
 
41h 
 
0 
 
0 
  8 
 
 
8 
 21e,i 
 
53 
 
0 
 
49 
 
18 
  31 
 
46 
 
0 
 
0 
  9e 
 
 
9 
 22 
 
42 
 
0 
 
0 
 
19 
  32e 
 
21 
 
0 
 
0 
 10 
 
 
10 
 23 
 
31 
 
0 
 
0 
 
20 
  33 
 
18 
 
0 
 
0 
aGP1: MeOH (30 mL), diene (2 equivalent), NaIO4(0.83 mmol), hydroxamic acid (0.83 mmol), stirred at rt, 2-4 h. At completion, the solvent evaporated 
and the product was purified by silica gel chromatography. Isolated yields quoted after purification bGP2: MeOH(5 mL), diene (2 equivalent), CuCl2 (0.06 
mmol), 2-ethyl-2-oxazoline (0.12 mmol),hydroxamic acid (0.63 mmol), stirred at rt in air 2-6 h. At completion, the solvent evaporated and the product was 
purified by silica gel chromatography. Isolated yields quoted after purification. cGP3: Toluene (5 mL), diene (2 equivalent), CuCl2 (0.14 mmol), 2-ethyl-2-
oxazoline (0.28 mmol),, hydroxamic acid (1.40 mmol), heated under reflux and stirred in air,  4-20 h. At completion, the solvent evaporated and the product 
was purified by silica gel chromatography. Isolated yields quoted after purification. dReference 12. eX-ray structure obtained in this study. fReference 9. 
gReference 13. hEne and methanolysis products also observed. iReferences 14 and 15. Note: All chiral cycloadducts are racemic. 
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   11                                 12 
13 
 
Initially, in situ oxidations of the hydroxamic acids 1-12 with sodium periodate in the presence of 
cyclohexa-1,3-diene or 2,3-dimethyl-1,3-butadiene were employed to establish whether cycloadducts 
can be formed (Table 1, Entries 1-20, method GP1). The reactions were complete in 4 hours with low to 
moderate yields of 13-53% of the desired cycloadducts 14-33 from hydroxamic acids 1-10. However, 
two hydroxamic acids, N-hydroxy-2-(pyridin-2-yl)acetamide 11 and 2-amino-N-hydroxybenzamide 12, 
gave only black tars after oxidation.  
 
The aerobic oxidation procedure (method GP2), successfully used on N-(benzyloxycarbonyl)-
hydroxylamine (Scheme 1), with 10 mol% CuCl2 and 20 mol% 2-ethyl-2-oxazoline at room temperature 
in methanol was then applied to hydroxamic acids 1-10 (Table 1). Only three hydroxamic acids 1-3 
gave the expected cycloadducts 14-16 from cyclohexa-1,3-diene (Table 1, Entries 1-3, GP2) and 
cycloadducts 24-26 from 2,3-dimethyl-1,3-butadiene (Table 1, Entries 11-13, GP2). Nevertheless, the 
cycloadduct yields from this method of 90-99% were remarkably high compared to 13-51% yields with 
the periodate method for the three hydroxamic acids 1-3. 
 
 
Nitroso ene products were also present from the copper-catalyzed oxidations of acids 1 and 2 with 
dimethyl-1,3-butadiene (Table 1, Entries 11 and 12, GP2). The NDA:ene ratios were 6:1 (24:34) and 
9:1 (25:35) from 1 and 2, respectively, indicating that the nitroso intermediate from 2 was more 
selective than the nitroso species from 1. Despite several attempts, the ene products 34 and 35 could not 
be isolated as pure compounds. These ene products were not observed with the periodate method (GP1) 
here and elsewhere,12 suggesting that the copper method promoted the nitroso-ene process. Curiously, 
the chiral hydroxamic acid 3 did not give an ene product using the copper procedure (Table 1, Entry 
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13), which might be interpreted by the accessibility of several conformations, all of which are reactive 
with no major conformation having an ability to control facial reactivity effectively. 
 
A third aerobic oxidation method (GP3) was applied to hydroxamic acids 4-10 using refluxing toluene 
instead of methanol at room temperature to facilitate the generation of the nitroso intermediates. The 
expected cycloadducts were formed in 49-78% yields from cyclohexa-1,3-diene with hydroxamic acids 
4-8 (Table 1, Entries 4-8, GP3) but no cycloadducts were obtained from 2,3-dimethyl-1,3-butadiene 
with the same acids (Table 1, Entries 14-18, GP3). This suggested that cyclohexa-1,3-diene was a much 
more efficient reagent than 2,3-dimethyl-1,3-butadiene in the nitroso-Diels-Alder process under these 
reaction conditions.16 
 
No cycloadducts were obtained from the hydroxamic acids containing pyridyl groups, 9 and 10, (Table 
1, Entries 9, 10, 19, 20) or from hydroxamic acids 11 and 12 (Chart 1) when the copper-catalyzed 
oxidation methods (GP2 and GP3) were used. It appeared that chelation takes place between the pyridyl 
or amine group and the copper complex preventing the oxidation process, as indicated by the rapid 
formation of an insoluble light blue precipitate which did not dissolve even after several days and no 
further reaction occurred.  
 
The hydroxamic acids, phenyl hydroxycarbamate 1 and 1-hydroxy-3-phenylurea 2, gave high yields of 
the cycloadducts with cyclohexa-1,3-diene and 2,3-dimethyl-1,3-butadiene using the room temperature 
copper catalyst method (GP2), hence, this method was examined further on 1 and 2 with six dienes, 
cyclopentadiene, dimethylanthracene (DMA), 1,4-dimethyl-1,3-butadiene, 1,4-diphenyl-1,3-butadiene, 
1-hydroxymethyl-4-methyl-1,3-butadiene and 2-methyl-1,3-butadiene (Table 2). The yields of the 
cycloadducts from these dienes were also high (90-99 %), except for the reactions with DMA and 1,4-
diphenyl-1,3-butadiene. These latter reactions required longer times of 24-48 hours, yet were still not 
complete, giving lower yields of the cycloadducts (30-82%). The known cycloadduct 46 from 2 and 
DMA undergoes cyclo-reversion on standing,17 and thus a 10% yield was estimated here (Table 2, Entry 
8). 
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Table 2. Reactions of various dienes with nitroso compounds prepared in situ from copper-catalyzed oxidations of 
hydroxamic acids, 1 and 2. 
 
 
Diene Entrya Product(s) from 1 
 
Yieldb Entrya Product(s) from 2 
 
Yieldb 
 
 
 
 
1 
 
  36c 
 
 
 
99 
 
 
7 
 
  45d 
 
 
96 
 
 
 
2 
  37 
 
 
 
80e 
 
 
8 
  46h 
 
 
(10)f, g 
 
 
 
 
3 
  38 
 
 
93 
 
 
9 
  47 
 
 
97 
 
 
 
 
 
4 
 
  39 
 
 
 
82e 
 
 
10 
 
  48 
 
 
30f 
 
 
 
 
5 
         
40 proximal                    41 distal 
40:41 Ratio 1 : 1 
 
 
 
93 
 
 
11 
        
49 proximal                      50 distal 
49:50 Ratio 1.5 : 1.0 
 
 
 
90 
 
 
 
 
6 
 
42 distal              43 proximal 
44 
 
42:43:44 Ratio 1.9 : 1.1 : 1.0 
 
 
 
90 
 
 
12 
    
51 distal                      52 proximal 
53 
 
51:52:53 Ratio 7.4 : 1.6 : 1.0 
 
 
 
95 
a For reactions of 1 and 2 with two other dienes see Entries 1, 2, 11 and 12 in Table 1. b From GP2 – see Table 1 for details. Isolated yields quoted after 
purification. cX-ray structure determined in this study. d Reference 12. e After 24 h. f After 48 h. g Yield not accurately obtained due to cyclo-reversion 
process of the cycloadduct. h Reference 17. Note: All chiral cycloadducts are racemic.
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The unsymmetric diene, 1-hydroxymethyl-4-methyl-1,3-butadiene, upon reaction with the oxidation 
product of acid 1, gave two cycloadducts 40 and 41 in equal amounts indicating no preference for one 
adduct over the other (Table 2, Entry 5). However, a preference of one cycloadduct 49 over adduct 50 
was observed when the oxidation product of acid 2 was employed, with a proximal:distal ratio of 3:2 
showing some selectivity (Table 2, Entry 11). The identities of 40, 41, 49 and 50 were determined with 
the aid of 2D 1H NOESY spectra. The product selectivities increased when 2-methyl-1,3-butadiene is 
used with ratios of 1.7:1 for distal:proximal adducts 42:43 from 1 (Table 2, Entry 6), and 4.5:1 for 
distal:proximal adducts 51:52 obtained from 2 (Table 2, Entry 12). In addition, there was an increase in 
selectivity of the adducts over the ene products (44 and 53) observed in the reactions with a 3:1 
NDA:ene ratio for 1 and 9:1 NDA:ene ratio for 2. Despite attempts, the cycloadduct 50 and the ene-
products 44 and 53 could not be isolated as pure substances. The identities of 42, 43, 51 and 52 were 
determined on the basis of similar cycloadducts reported elsewhere.8 
 
The cycloadducts reported herein were all characterized by 1H NMR, 13C NMR, IR spectroscopies and 
mass spectrometry (Figures S14-S45 for NMR spectra). While most adducts showed only one 
conformer in solution from NMR studies at ambient temperature, the bicyclic oxazaoctene 22 existed as 
a pair of rotamers (Figure 1). NMR observations of a pair of rotamers have been reported previously for 
21 at lower temperatures.9,15 
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Figure 1. Comparison of observed and computed (GIAO) 1H and 13C NMR spectra for the two rotamers 
of 22. Peaks with asterisks correspond to chloroform as solvent. 
 
Crystal Structures 
X-ray crystal determinations were carried out on three hydroxamic acids (2, 3 and 9), five adducts from 
the cyclohexadiene nitroso-Diels-Alder (NDA) reactions (14-17 and 21), two from 2,3-dimethyl-1,3-
butadiene NDA reactions (25 and 32) and one from the cyclopentadiene NDA reaction (36) (Figures 
S46-48 and Table S1). The cyclohexadiene NDA adducts may contain four distinct bicyclic 
oxaazaoctene geometries A-D (Figure 2). Compound 14 has conformer B, where the carbonyl C=O 
bond is orientated syn to the N-O bond, and the C=O group located adjacent to the C=C double bond in 
the bicycle whereas adducts 15-17 and 21 were of conformer A type, with the carbonyl C=O bond 
orientated anti to the N-O bond (Figure 3).  
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The bicyclic oxaazaoctene geometries structurally characterized previously included two examples of 
conformer B with a -COOR group (R = cyclohexyl containing -Me and -CMe2-naphthyl substituents)18 
and a -COPh group19 at the bicyclic nitrogen atom. Four reported geometries were of conformer A with 
-COOCH2Ph groups,8,20 a -CO-camphoryl21 and a -COCH(OH)Ph22 group at the bicyclic nitrogen. For 
bicyclic oxaazaoctenes structurally characterized to date, the -COOR and -COPh groups at the bicyclic 
nitrogen atom adopted the anti-conformer A or the syn-conformer B whereas others, with -COR groups 
at the bicyclic nitrogen atom, adopted the anti conformer A. All of these bicyclic oxaazaoctenes, 14-17 
and 21, contained the C=O group located adjacent to the C=C double bond in the bicycle. Conformers C 
and D have not been reported for these systems and were assumed to be less favorable. 
 
The dimethylbutadiene NDA adducts, 25 and 32, contain the carbonyl C=O bond oriented anti to the N-
O bond with -CONHPh and -COPy groups at the oxazine nitrogen atom. Many anti-conformer 
geometries have been determined with a -COR group at the oxazine nitrogen atom.23 There have been 
reported oxazine structures where the carbonyl C=O bonds were oriented syn to the N-O bond with -
COOR (R = tBu, PhCH2) groups at the cyclic nitrogen atom.24 There seems to be little preference for 
either the syn- or anti-geometry in oxazines with -COR groups at the nitrogen atom except for -
CONHR, for which the anti geometry is expected, with a distance of 2.183 Å found for the favorable N-
H..O interaction in 25.  
 
The cyclopentadiene NDA adduct 36 contained a COOPh group at the nitrogen atom of the bicyclic 
oxaazaheptene skeleton where the C=O bond was syn to the N-O bond. The only published bicyclic 
oxaazaheptene with a -COR group at the nitrogen atom is the anti conformer for R = -
CHMeNHOCOCH2Ph.25 
 
Table 3. Conformers A-D and calculated relative and rotation barrier energies (kcal mol-1) for 14, 15, 21 and 22.
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Figure 2. Views of the substituents at N3 with respect to the bicyclic framework in molecular structures of 14, 15 and 21.  
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Computations on NDA Cycloadducts 
Geometry optimizations were carried out via DFT calculations in the gas-phase at the B3LYP/6-31G* 
level on 14, 15 and 21 to compare with their solid-state geometries as determined by X-ray diffraction, 
and also to estimate the relative energies of the syn and anti conformers A-D. Comparison between the 
bond lengths of X-ray and computed geometries revealed a very good agreement with differences not 
exceeding 0.011 Å, except for the N-C bonds between N-O and C=O, which are computed to be longer 
by 0.017-0.034 Å than observed experimentally (Table S2). The latter differences may have been due to 
an overestimation of the lone pair contribution from the nitrogen donor atom and the electron-poor 
carbonyl carbon atom with the B3LYP functional. Similar N-C bond length overestimations (0.014-
0.027 Å) were found for optimized geometries of 14, 15 and 21 using the larger 6-311++G** versus 6-
31G* basis set. 
 
Relative energies for the conformers A-D of 14, 15 and 21 showed a preference for the anti conformer 
A (Table 3). While the preference was in accord with observed experimental geometries for 15 and 21, 
the experimental geometry in 14 is the syn conformer B. Conformer B was only 0.8 kcal mol-1 higher in 
energy than conformer A for 14. As two rotamers of 22 were observed by NMR spectra at room 
temperature (Figure 1), conformers A-D for 22 were also examined computationally with the syn 
conformer B calculated to be lower in energy than the anti-conformer A by only 0.1 kcal mol-1 in 
energy.  
 
The rotational energy barriers between anti and syn conformers A and B of 14, 15, 21 and 22 were 
estimated computationally (Figure 1). The calculated value of 14.1 kcal mol-1 was in good agreement 
with the reported14 experimental value of 13.8 kcal mol-1 for 21. The lower energy barrier of 13.8 kcal 
mol-1 for 14 suggested that 14 was fluxional in solution between the two conformers at room 
temperature as observed for 21. While the rotational energy barrier of 17.4 kcal mol-1 for 15 suggested 
that two conformers were present in the NMR spectra, the strong preference for the anti conformer A 
over the syn form B was reflected by an energy difference of 8.8 kcal mol-1. This indicated that only the 
anti conformer for 15 was observed experimentally in solution and likely to be due to the favorable 
intramolecular hydrogen interaction between the hydrogen atom at N1 and the oxygen atom O2 in the 
bicycle with an experimentally determined distance of 2.136 Å with the hydrogen atom in a calculated 
position (Figure 2).  
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The NMR spectra of 22 showed both conformers at room temperature (Figure 1) as the anti and syn 
conformers were very similar in energies and the rotational energy barrier between these conformers in 
22 were slightly higher than in 14 and 21 (Figure 2). The syn conformer was the major component 
based on comparison of observed NMR chemical shifts with computed GIAO-NMR chemical shifts 
where the computed peak intensities assumed a 3:1 syn:anti conformer ratio. The agreement between 
observed and computed 1H NMR shifts was not expected to be very good as 1H NMR chemical shifts 
are strongly influenced by the nature of the solvent. Nevertheless, the agreement between observed and 
computed 13C NMR shifts for 22 was very good when the different observed peak intensities expected 
from different types of carbon groups were taken into account which were not modeled 
computationally. 
 
Reaction Pathway Computations 
There have only been three computational studies on intermolecular nitroso-Diels-Alder (NDA) 
reactions of nitroso species with dienes.26,27 The excellent 2001 study by Leach and Houk looked at the 
transition states for reactions of several nitroso species (RNO where R = H, alkyl, Ph, s-trans CHO and 
s-cis CHO) with butadiene and substituted butadienes with MeO, Me and CN as substituents.26 They 
showed that the endo-NDA pathway was the favored one over the exo-NDA and nitroso-ene pathways 
for all reactions.  
 
From the 2001 investigation, the transition state enthalpies from the acyl nitroso HCONO species and 
butadiene to the nitroso-Diels-Alder adduct (III) are only 3.6 and 4.9 kcal mol-1 above the starting 
butadiene and the nitroso species s-trans HCONO and s-cis HCONO, respectively. These values were 
confirmed here if the starting geometries were assumed to be the trans-butadiene and s-trans-HCONO 
(I in Figure 3, Tables S3 and S4). However, the cis-butadiene geometry was clearly the precursor along 
with s-trans-HCONO (II in Figure 3) to the endo NDA transition state (TS-II,III) so the transition-state 
enthalpy was calculated as a negative(!) value at -0.1 kcal mol-1 instead of the reported value of 3.6 kcal 
mol-1. Obviously, there must be a local minimum (LM) between cis-butadiene and s-trans HCONO that 
is lower in energy than the NDA transition state and such a local minimum II(LM) (Figures 3 and 4) 
was found with an energy of 1.8 kcal mol-1 lower than the energy of the NDA transition state (TS-II,III). 
The intriguing aspect of the acyl nitroso-butadiene pathway is that the transition-state energy of the 
geometry located (TS-I,II in Figure 3) in the s-trans and s-cis butadiene conversion was higher than the 
transition-state energy of the NDA adduct formation irrespective of whether local minima (LM) are 
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located (Figure 3). This view indicated that acyl nitroso species are super-reactive species, as noted 
elsewhere.28 
 
 
Figure 3. Reaction pathways (top) without local minima of starting molecules and (bottom) with local minima of the starting 
molecules. Energies in parentheses are based on computed enthalpy values and are in agreement with those reported in 
reference 26. 
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Figure 4. Geometries of butadiene-acylnitroso association complex local minima. 
 
The pathways of the reactions carried out experimentally in this study were explored computationally 
using MeOCONO and MeNHCONO as models for PhOCONO and PhNHCONO species generated 
from oxidations of the hydroxamic acids 1 and 2, respectively. While the s-trans-form was much more 
stable than the s-cis-form by 3.3 kcal mol-1 in HCONO, the energy differences between s-trans and s-cis 
forms were much smaller in MeOCONO and MeNHCONO being only 0.8 and 0.1 kcal mol-1, 
respectively, with the most stable forms being s-cis and s-trans for MeOCONO and MeNHCONO, 
respectively (Table S5). Both conformations were considered in all NDA reaction pathways 
investigated here. The s-trans-forms were the preferred reagents in all computed NDA reaction 
pathways containing the lowest transition energies overall. 
 
The relative energies of the local minima (LM), transition states (TS) and products are shown in Figure 
5 and Tables S6 and S7 with cyclohexa-1,3-diene, 2,3-dimethylbutadiene, 1,4-diphenylbutadiene and 
9,10-dimethylanthracene (DMA) as the dienes in reaction pathways with MeOCONO and 
MeNHCONO. The cyclohexa-1,3-diene - acyl nitroso pathway was clearly very favorable with: i) NDA 
transition state energies of only 2.4-2.8 kcal mol-1 higher than the energies of the local minima of the 
reactants; and ii) the energies of adducts being lower by over -30 kcal mol-1 than the energies of the 
local minima of the starting reactants. The DMA - acyl nitroso pathway was less favorable with higher 
energy barrier of 5.9 kcal mol-1 for MeOCONO which explained the need for a longer reaction time to 
obtain a high yield of the cycloadduct 37. The energy of the MeNHCONO cycloadduct at -15.4 kcal 
mol-1, relative to the starting nitroso species and DMA, shows that it was susceptible to cyclo-reversion 
thus the corresponding known17adduct 46 could not be obtained in high yield experimentally. 
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Figure 5. Relative energies (kcal mol-1) for computed nitroso-Diels-Alder model pathways. 
 
For the acyclic dienes, the energy barriers for isomerization from the s-trans to s-cis diene geometries 
are higher than the energies of the NDA transition states in all cases except for 2,3-dimethylbutadiene 
and MeNHCONO as shown in Figure 6. The experimental s-trans- to s-cis diene rotational 
interconversion barriers for 2,3-dimethylbutadiene and 2-methyl-1,3-butadiene were estimated at 3.4 
and 3.9 kcal mol-1, respectively, which were lower than our computed ‘gas-phase’ values of 4.8 and 6.7 
kcal mol-1.29 As discussed for the simple model HNO + butadiene reaction, there were competing 
energy barriers between the s-trans and s-cis diene rotational interconversion and the NDA adduct 
formation. The longer reaction time required for a high yield of the cycloadduct 39 from 1,4-
diphenylbutadiene was due to the comparatively high energy s-trans to s-cis diene conformation barrier 
of 10.0 kcal mol-1, and the s-trans diene was more stable than the s-cis diene by 6.2 kcal mol-1. The 
NDA adduct from 1,4-diphenylbutadiene and MeNHCONO was only -16.5 kcal mol-1 lower in energy 
compared to the combined energy of the starting reactants thus cyclo-reversion would be expected in 
48. 
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Figure 6. Relative energies (kcal mol-1) for computed acyclic diene and nitroso-Diels-Alder model 
pathways. 
 
The observed NDA products from in situ oxidations of 1 and 2 in the presence of 2-methyl-1,3-
butadiene gave distal and proximal isomers with a preference for the distal form, particularly from urea 
2 (Table S7). The computed reaction pathways showed a preference for the proximal form with 
MeOCONO but distal form with MeNHCONO and transition state energy differences of only 0.7 and 
0.4 kcal mol-1, respectively. Such small differences were reflected in both proximal and distal forms 
being observed experimentally. The reported19 reaction of MeOCONO with 2-[(tert-
butyldimethylsilyl)oxy]methyl-1,3-butadiene gave the proximal form as the major isomer, hence, the 
isomer ratio would depend on whether MeOCONO or PhOCONO was used. 
  
The presence of ene products, 34, 35, 44 and 53, from 2,3-dimethylbutadiene and 2-methylbutadiene 
with 1 and 2 suggested that ene reaction pathways from these dienes with MeOCONO and 
MeNHCONO are competing with NDA pathways. By computing the pathways with s-cis or s-trans 
dienes as starting reactants, we located transition states with energies at least 5 kcal mol-1 higher than 
the corresponding endo NDA transition state energies (Figure 7 and Table S8). Attempts to establish 
complete ene reaction pathways with diradical species were unsuccessful. The ene products observed 
were assumed to form from reaction pathways involving the copper complex as: i) the predicted 
transition state energies for the ene pathways were too high to compete with the NDA pathways; and ii) 
the copper-free periodate method (GP1) did not give ene products from 1 and 2.  
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Figure 7. Nitroso-ene pathways with relative energies in kcal mol-1.  
 
Unlike intramolecular NDA pathways where predictions of relative transition energies are 
straightforward,30 intermolecular NDA pathways are difficult to model given that there are many 
possible starting points, different conformers and local minima of the two reactant molecules. This 
difficulty is compounded by super-reactive acyl nitroso species, such as MeOCONO and MeNHCONO, 
where the endo-NDA transition state can be only 2.0 kcal mol-1 higher than the starting diene and 
nitroso species. Nevertheless, the computations here showed that the preferred reaction pathway was via 
the endo-NDA transition-state, over both the exo-NDA and ene transition-states (Table S9), as also 
reported elsewhere.26 The data also showed that the endo-NDA transition-states can be lower in energy 
than the transition states involved in the s-trans to s-cis diene isomerization processes for acyclic dienes.  
 
The low yields of cycloadducts 46 and 48 from urea 2 and 9,10-dimethylanthracene and 1,4-
diphenylbutadiene (Table 2, entries 8 and 10) can be understood by the fact that the calculated energies 
of the cycloadducts were close in energies to the combined energies of their corresponding diene and 
nitroso species, and thus were susceptible to cycloreversion processes. As the ene reaction pathways 
show considerably higher energy barriers than the NDA pathways for 2,3-dimethylbutadiene and 2-
methylbutadiene with nitroso species, we suggest here that the copper complex present in solution is 
involved in the ene pathways and thus, the copper-mediated ene pathways compete with the NDA 
pathways. This assumption is supported by a reported10 copper-mediated procedure specific for 
reactions of acylnitroso species with alkenes to give ene products in high yields at ambient 
temperatures. 
 
Summary and conclusions 
From the work shown here, we conclude that: 1) the copper-oxazoline complex is an excellent catalyst 
for the aerobic oxidation of acyl hydroxamic acid to generate the corresponding acyl nitroso species; 2) 
this system can only be used with a hydroxamic acid containing a hetero-atom between the aryl and 
carbonyl group; 3) the nitroso species generated in situ can be trapped by most dienes resulting in the 
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corresponding cycloadducts; 4) the yield of the products varied from high to moderate, depending upon 
the reaction time because there is competitive decomposition of the nitroso species, reducing the yield 
of the NDA adduct. The longer the trapping time (slower NDA reaction), the lower the yield, generally; 
5) the chemoselectivity of this system depends upon the reactivity of the hydroxamic acid - the higher 
the reactivity, the lower the chemoselectivity. Overall, the catalytic aerobic oxidation is a particularly 
efficient, mild, clean, simple and environmentally benign method for generating acyl nitroso species in 
situ and trapping them via a NDA reaction. When these types of reactions are examined by DFT 
calculations, the preference for endo transition-states, over exo and ene transition states, was confirmed. 
Interestingly, for the super reactive acyl nitroso species, diene rotational conformational interconversion 
between s-cis and s-trans forms, can be slower than the nitroso-DA reaction, since the transition-state 
energies are lower for the DA reaction via the endo transition-state. This could explain variable yields in 
some cases, because the acyl nitroso compounds were inherently unstable and decomposition could 
compete on this basis. In addition, the inherent reversibility in these reactions also likely played a major 
role in reaction yields. Calculated energies confirm the greater reversibility of certain diene - nitroso 
species combinations, again, providing time for nitroso species decomposition. The reversibility has 
also likely to impact upon observed both regio- and stereo-control in these reactions. This issue has not 
been addressed to a major extent in the literature, but the prediction of considerable reversibility in these 
reactions means that a detailed examination of kinetic versus thermodynamic effects on the reaction 
outcome would shed further light upon the selectivity in the nitroso-DA reactions. 
 
Experimental Section 
 
General 
All reactions were performed in the presence of air, unless otherwise stated. All reagents were 
purchased from commercial sources and were used as received without further purification unless 
otherwise stated. Solvents (AR grade) were used as received. 1H NMR spectra were recorded at 400, 
500, 600 or 700 MHz and 13C{1H} spectra were recorded at 101, 125, 150, or 176 MHz, in CDCl3 or 
DMSO-d6 as solvents. 1H NMR chemical shifts are reported with reference to TMS using residual 
proton on non deuterated solvent (CDCl3: 7.26 ppm; DMSO-d6: 2.50 ppm; 3.33 ppm for water present 
in DMSO-d6) whereas 13C NMR spectra are reported with reference to TMS using the carbon signals of 
the deuterated solvent (CDCl3: 77.23 ppm; DMSO-d6: 39.52 ppm). All chromatography was carried out 
using 40-63 µm silica gel. The removal of solvent was performed on a rotary evaporator under vacuum. 
Melting points were determined using a melting point apparatus and are uncorrected. Low resolution 
	   20	  
mass spectrometry was carried out on a TQD equipped with a UPLC and an electrospray ion source, 
and high resolution mass spectrometry was carried out on a TOF-MS equipped with an electrospray ion 
source. 
 
Hydroxamic acid syntheses 
Compounds 1-12 have been reported elsewhere31-42  using different procedures to those described here. 
Phenyl hydroxycarbamate 31 1  
 
A solution of phenyl chloroformate (5.32 g, 34.0 mmol) in ether was added dropwise in 30 min to a 
stirred solution of hydroxylamide hydrochloride (2.36 g, 34.0 mmol) and potassium carbonate (5.17 g, 
37.4 mmol) in 30 mL of ether and 5 mL of water at 5 °C. After the addition, the reaction was stirred at 
room temperature for 4 h. The organic layer was separated and dried over MgSO4. The solvent was 
evaporated in vacuo to yield a white solid product 1 (3.10 g, 59%) this compound was used in the next 
experiment without purification; m.p. 98 – 101 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.33 (s, 1H), 
9.08 (s, 1H), 7.42 – 7.36 (m, 2H), 7.25 – 7.19 (m, 1H), 7.13 – 7.07 (m, 2H), 13C{1H} NMR (101 MHz, 
DMSO-d6) δ 155.5, 150.7, 129.4, 125.1, 121.5; FTIR (thin film) inter alia 3299, 1687 (C=O), 1511, 
1492, 1284, 1201, 1105, 795, 687; LRMS (ESI+) m/z 176.1 (M+ +Na); HRMS (ESI+) m/z Calcd for 
C7H7NO3Na 176.0324 found 176.0333. 
 
1-Hydroxy-3-phenylurea32,33 2 
 
A solution of phenylisocyanate (4.00 g, 33.6 mmol) in 10 mL of DCM was added dropwise over 30 min 
to a solution of sodium hydroxide (1.34 g, 33.6 mmol) and hydroxylamine hydrochloride (2.33 g, 33.6 
mmol) in 5 mL of water and 60 mL of DCM at 0 °C. After the addition, the reaction was warmed to the 
room temperature and stirred for 3 h to yield a white solid. The reaction was washed by 20 mL of water 
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and 20 mL of DCM. The precipitate was collected by filtration and recrystalized from ethyl acetate to 
give the product 2 as a white solid (2.53 g, 50 %); m.p. 148 – 150 °C; 1H NMR (400 MHz, DMSO-d6) δ 
8.96 (s, 1H), 8.81 (s, 1H), 8.75 (s, 1H), 7.59 (d, J = 8.5 Hz, 2H), 7.23 (t, J = 7.9 Hz, 2H), 6.95 (t, J = 7.3 
Hz, 1H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 159.0, 139.8, 128.9, 122.6, 119.6; FTIR (thin film) 
inter alia 3221, 2951, 2894, 1630, 1595, 1537, 1501, 1449, 1074, 755, 688 cm-1; LRMS (ESI+) m/z 
175.1 (M+ +Na); HRMS (ESI+) m/z Calcd for C7H8N2O2Na 175.0483 found 175.0483. 
 
(R)-1-Hydroxy-3-(1-phenylethyl)urea32,34 3 and N-Hydroxy-N’-[(R)-1-Phenylethyl]-N-[(R)-1-
Phenylethylcarbamoyl]urea 13 
 
A solution of (R)-(1-isocyanatoethyl)benzene (1.00 g, 6.79 mmol) in 10 mL of DCM was added 
dropwise over 30 min to a solution of sodium hydroxide (0.27 g, 6.79 mmol) and hydroxylamine 
hydrochloride (0.47 g, 6.79 mmol) in 1 mL of water and 20 mL of DCM at 0 °C. After the addition, the 
reaction was warmed to the room temperature and stirred for 3 h. The reaction was washed by 20 mL of 
water and 20 mL of DCM. The organic phase was separated and dried over MgSO4. The removal of 
solvent gave a colorless oil which then was separated by column chromatography (ethyl acetate as 
eluent) to yield 0.60 g (49%) of product 3; m.p. 106-108 °C ; 1H NMR (400 MHz, DMSO-d6) δ 8.67 (d, 
J = 0.8 Hz, 1H), 8.40 (s, 1H), 7.42 – 7.34 (m, 4H), 7.30 – 7.24 (m, 1H), 7.00 (d, J = 8.7 Hz, 1H), 4.94- 
4.86 (m, 1H), 1.45 (d, J = 7.1 Hz, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 161.0, 145.8, 128.6, 
126.9, 126.5, 48.6, 23.1; FTIR (thin film) inter alia 3311, 2931, 1649 (C=O), 1514, 766, 698 cm-1; 
LRMS (ESI+) m/z 203.5 (M+ +Na); HRMS (ESI+) m/z Calcd for C9H12N2O2Na 203.0796 found 
203.0796 and an orange oil side product 13 (0.31 g, 13%); 1H NMR (400 MHz, CDCl3) δ 9.30 (s, 1H), 
7.32 – 7.08 (m, 12H), 4.87 (s, 2H), 1.45 (s, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 153.1, 142.0, 
127.7, 126.4, 124.9, 49.2, 21.7; FTIR (thin film) inter alia 3270, 3029, 2971, 1691 (C=O), 1658 (C=O), 
1491, 1209, 696 cm-1; LRMS (ESI+) m/z 350.7 (M+ +Na); HRMS (ESI+) m/z Calcd for C18H21N3O3Na 
350. 1481 found 350.1472. 
 
General procedure of hydroxamic acid synthesis from esters (GPHA)35 
Four equivalents of sodium hydroxide were dissolved in water followed by two equivalents of 
hydroxylamine hydrochloride. Then, this solution was added dropwise to the appropriate ester in 
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methanol. The reaction was stirred at room temperature for 4 h and monitored by TLC. When the 
reaction was finished, the solution was acidified with 5% HCl to pH 5.5. The solvent was removed in 
vacuo to yield a mixture of product and sodium chloride, which was then redissolved in methanol. The 
sodium chloride was removed by filtration. The methanol was removed in vacuo to give the 
corresponding product, which then recrystallized from hot water to give the pure product. 
 
N-Hydroxy-2-phenylacetamide36 4  
 
The reaction was performed according to GPHA, using methylphenylacetate (10.2 g, 67.9 mmol) in 200 
mL of methanol, sodium hydroxide (10.9 g, 272 mmol), hydroxylamine hydrochloride (9.4 g, 135 
mmol) in  200 mL of water. The product 4 was isolated as an off-white solid (5.6 g, 54%); m.p. 139–
142 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.67 (s, 1H), 8.84 (s, 1H), 7.32 – 7.19 (m, 5H), 3.28 (s, 2H); 
13C{1H} NMR (101 MHz, DMSO-d6) δ 167.0, 136.1, 128.9, 128.1, 126.4, 39.4; FTIR (thin film) inter 
alia 3186, 3002, 2902, 1631 (C=O), 1548, 1495, 1455, 1054, 978, 715; LRMS (ESI-) m/z 150.2 (M+ -
H); HRMS (ESI+) m/z Calcd for C8H8NO2 150.0555 found 150.0555. 
 
N-Hydroxy-3-phenylpropanamide36 5  
 
The reaction was performed according to GPHA, using ethylhydrocinnamate (9.4 g, 52.7 mmol) in 200 
mL of methanol, sodium hydroxide (8.4 g, 210 mmol), hydroxylamine hydrochloride (7.3 g, 105 mmol) 
in 200 mL of water. The product 5 was isolated as a white solid (4.9 g, 56%); m.p. 75 – 77 °C; 1H NMR 
(400 MHz, CDCl3) δ 9.20 (s, 2H), 7.25 – 7.20 (m, 2H), 7.18 – 7.10 (m, 3H), 2.87 (t, J = 8 Hz, 2H), 2.38 
(t, J = 8 Hz, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 171.1, 140.2, 128.6, 128.3, 126.4, 34.6, 31.3; 
FTIR (thin film) inter alia 3296, 3062, 2782, 1662 (C=O), 1626, 1557, 1496, 1455, 1062, 995, 695; 
LRMS (ESI+) m/z 188.2 (M+ +Na); HRMS (ESI+) m/z Calcd for C9H11NO2Na 188.0687 found 
188.0689. 
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N-Hydroxy-4-phenylbutanamide36,37 6  
 
4-Phenylbutyric acid (7.4 g, 45.1 mmol), NMM (5.0 g, 50.5 mmol), DMAP (0.06 g, 0.05 mmol) and 
hydroxylamine hydrochloride (3.5 g, 50.5 mmol) were dissolved in 150 mL of DCM. The mixture was 
stirred and cooled to 0 °C. Then cyanuric chloride (2.5 g, 15.0 mmol) was added to the solution and the 
mixture was warmed to room temperature. The reaction was stirred for 24 h. After completion, the 
solution was filtered through Celite, then washed with 45 mL of 1 M HCl (3X). The organic layer was 
separated and dried over MgSO4. The solvent was evaporated in vacuo to yield a white solid product, 
which was then purified by silica gel column chromatography (EtOAc as eluent) to give product   6 
(2.00 g, 25%); m.p. 71 – 74 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.36 (s, 1H), 8.71 (s, 1H), 7.28 – 
7.23 (m, 2H), 7.18 – 7.14 (m, 3H), 2.54 (t, J = 8.0 Hz, 2H), 1.95 (t, J = 8.0 Hz, 2H), 1.82 – 1.71 (m, 
2H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 168.8, 141.6, 128.3, 128.3, 125.7, 34.6, 31.8, 27.0; FTIR 
(thin film) inter alia 3170, 3024, 2908, 1622 (C=O), 1542, 1495, 1459, 1065, 1016, 742, 694; LRMS 
(ESI+) m/z 202.2 (M+ +Na); HRMS (ESI+) m/z Calcd for C10H13NO2Na 202.0844 found 202.0849. 
 
N-Hydroxy-5-phenylpentanamide38  7  
 
Hydrogen chloride gas, generated from dropping 36% HCl into 98% H2SO4, was bubbled into a 
solution of 5-phenylvaleric acid (5.0 g, 28.1 mmol) in 150 mL of methanol at room temperature for 15 
min. Then sodium hydroxide (4.5 g, 112 mmol), and hydroxylamine hydrochloride (3.9 g, 56.2 mmol) 
in 100 mL of water were added dropwise to the solution. The reaction was stirred for 24 h and then 
acidified to pH 5.5 using 10% HCl. The solvents were removed under vacuum. The residue was 
redissolved in methanol and the sodium chloride was removed by filtration. The solvent then removed 
to yield a yellow oil, which was recrystalized from ether to yield a white solid product 7 (3.60 g, 67%); 
m.p. 68 – 71 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.32 (s, 1H), 8.67 (s, 1H), 7.27 (t, J = 7.5 Hz, 2H), 
7.20 – 7.14 (m, 3H) 2.56 (t, J = 6.7 Hz, 2H), 1.97 (t, J = 6.8 Hz, 2H), 1.63 – 1.39 (m, 4H); 13C{1H} 
NMR (101 MHz, DMSO-d6) δ 169.0, 142.0, 128.2, 128.2, 125.6, 34.8, 32.1, 30.5, 24.8; FTIR (thin 
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film) inter alia 3186, 3038, 2910, 1618 (C=O), 1434, 1085, 992, 962, 749, 698; LRMS (ESI+) m/z 
216.2 (M+ +Na); HRMS (ESI+) m/z Calcd for C11H15NO2Na 216.1000 found 216.1007.  
 
N-Hydroxybenzamide36 8  
 
The reaction was performed according to GPHA, using methylbenzoate (5.30 g, 38.9 mmol) in 100 mL 
of methanol, sodium hydroxide (6.23 g, 156 mmol), and hydroxylamine hydrochloride (5.41 g, 77.9 
mmol) in 100 mL of water. The product 8 was isolated as a white solid (3.4 g, 64%); m.p. 121 – 123 °C; 
1H NMR (400 MHz, DMSO-d6) δ 11.22 (s, 1H), 9.05 (s, 1H), 7.82 – 7.68 (m, 2H), 7.54 – 7.48 (m, 1H), 
7.48 – 7.36 (m, 2H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 164.7, 133.3, 131.6, 128.8, 127.3; FTIR 
(thin film) inter alia 3292, 3062, 2746, 1644, 1602, 1557, 1490, 1316, 1163, 1022, 897, 787, 689; 
LRMS (ESI+) m/z 138.2 (M+ +H); HRMS (ESI+) m/z Calcd for C7H8NO2 138.0555 found 138.055.	  
 
2-Pyridinehydroxamic acid39 9 
 
The reaction was performed according to GPHA, using ethyl-2-picolinate (5.00 g, 33 mmol) in 100 mL 
of methanol, sodium hydroxide (5.29 g, 132 mmol), and hydroxylamine hydrochloride (4.60 g, 66 
mmol) in 100 mL of water. The product 9 was isolated as a white solid (3.00 g, 66%); m.p. 119 – 120 
°C; 1H NMR (400 MHz, DMSO-d6) δ 11.46 (s, 1H), 9.24 (s, 1H), 8.63 (dt, J = 4.8, 1.3 Hz, 1H), 8.04 – 
7.97 (m, 2H), 7.64 – 7.57 (m, 1H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 162.2, 151.0, 149.4, 138.5, 
127.2, 122.7.; FTIR (thin film) inter alia  3264 (broad), 2778 (broad), 1662 (C=O), 1592, 1570, 1516, 
1475, 1177, 1030, 816; LRMS (ESI-) m/z 161.4 (M+ Na); HRMS (ESI+) m/z Calcd for C6H6N2O2Na 
161.0327 found 161.0323. 
 
3-Pyridinehydroxamic acid40 10  
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The reaction was performed according to GPHA, using ethyl nicotinate (5.00 g, 33 mmol) in 100 mL of 
methanol, sodium hydroxide (5.29 g, 132 mmol), and hydroxylamine hydrochloride (4.60 g, 66 mmol) 
in 100 mL of water. The product 10 was isolated as a white solid (2.70 g, 59%): m.p. 160 – 161 °C; 1H 
NMR (400 MHz, DMSO-d6) δ 11.37 (s, 1H), 9.59 – 8.99 (m, 1H), 8.89 (dt, J = 20.8, 10.4 Hz, 1H), 8.74 
– 8.61 (m, 1H), 8.18 – 8.00 (m, 1H), 7.49 (ddd, J = 7.9, 4.8, 0.8 Hz, 1H); 13C{1H} NMR (101 MHz, 
DMSO-d6) δ 162.9, 152.3, 148.3, 135.1, 128.9, 124.0; FTIR (thin film) inter alia 1634 (C=O), 1594, 
1495, 1472, 1422, 1305, 1024, 700; LRMS (ESI-) m/z 137.1 (M+ -H); HRMS (ESI-) m/z Calcd for 
C6H5N2O2 137.0351 found 137.0332. 
 
N-Hydroxy-2-(pyridin-2-yl)acetamide41 11 
 
The reaction was performed according to GPHA, using ethyl 2-pyridylacetate (2.00 g, 12.1 mmol) in 
50mL of methanol, sodium hydroxide (1.94 g, 48.4 mmol), and hydroxylamine hydrochloride (1.68 g, 
24.2 mmol) in 50 mL of water. The product 11 was isolated as a white solid (0.93g, 50%), which was 
used in the next experiment without purification: m.p. 159 – 161 °C; 1H NMR (600 MHz, DMSO-d6) δ 
10.93 (s, 1H), 8.97 (s, 1H), 8.57 (d, J = 4.3 Hz, 1H), 7.96 (dd, J = 7.6, 6.4 Hz, 1H), 7.52 (d, J = 7.8 Hz, 
1H), 7.47 – 7.41 (m, 1H), 3.64 (s, 2H); 13C{1H} NMR (151 MHz, DMSO-d6) δ 165.3, 154.5, 146.7, 
139.1, 124.9, 122.8, 40.5; FTIR (thin film) inter alia 1677 (C=O), 1645, 1600, 1546, 1442, 1044, 1012, 
797, 764, 616; LRMS (ESI+) m/z 175.4 (M+ Na); HRMS (ESI+) m/z Calcd for C7H8N2O2Na 175.0483 
found 175.0473. 
 
2-Amino-N-hydroxybenzamide42 12 
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The reaction was performed according to GPHA, using methyl 2-aminobenzoate (10.00 g, 66.2 mmol) 
in 200 mL of methanol, sodium hydroxide (10.60 g, 265 mmol), and hydroxylamine hydrochloride 
(9.20 g, 132 mmol) in 200 mL of water. The product 12 was isolated as a pale yellow solid (6.10 g, 
60%): m.p. 143-145 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.91 (s, 1H), 8.89 (s, 1H), 7.30 (dd, J = 
13.1, 6.5 Hz, 1H), 7.12 (ddd, J = 8.5, 7.2, 1.5 Hz, 1H), 6.69 (dd, J = 8.2, 1.0 Hz, 1H), 6.51 – 6.44 (m, 
1H), 6.22 (s, 2H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 166.8, 149.2, 131.5, 127.5, 116.2, 114.7, 
113.2; FTIR (thin film) inter alia 3163, 2950, 2856, 1618, 1560, 1493, 1449, 1348, 1249, 1021, 741, 
671; LRMS (ESI+) m/z 175.1 (M+ +Na); HRMS (ESI+) m/z Calcd for C7H8N2O2Na 175.0483  found 
175.0473. 
 
 
Nitroso-Diels-Alder reactions 
General Procedure 1, GP1: General procedure for the formation of acyl cycloadducts using sodium 
periodate oxidation of hydroxamic acids 
Hydroxamic acid dissolved in methanol (10 mL) was added dropwise to a solution of diene, and sodium 
periodate in methanol (20 mL) at room temperature. The reaction mixture was stirred for 4 h and was 
monitored by TLC. Then the solvent was removed under vacuum. The crude product was purified by 
silica gel chromatography (6:1 v/v, hexane/EtOAc). 
 
General Procedure 2, GP2: General procedure for the formation acyl cycloadducts using copper-
oxazoline catalyzed oxidation of hydroxamic acids in methanol 
To a methanol (5 ml) solution of 2 equivalents of diene, 10 mol% CuCl2 and 20 mol% 2-ethyl-2-
oxazoline was added the hydroxamic acid. The resulting solution was stirred and monitored by TLC. 
The completion of the reaction was confirmed by the disappearance of the starting material. The solvent 
was removed by evaporation and the crude product was purified by silica gel chromatography 
(hexane:ethyl acetate, 6:1 v/v, as eluent).  
 
General Procedure 3, GP3: General procedure for the formation of acyl cycloadducts using copper-
oxazoline catalyzed oxidation of hydroxamic acids in refluxing toluene 
To a toluene (5 ml) solution of 2 equivalents of diene, 10 mol% CuCl2 and 20 mol% 2-ethyl-2-
oxazoline was added the hydroxamic acid. The resulting solution was heated under reflux with stirring, 
and the reaction was monitored by TLC. The completion of the reaction was confirmed by the 
	   27	  
disappearance of the starting material. The solvent was removed by evaporation and the crude product 
was purified by silica gel chromatography (hexane:ethyl acetate, 6:1 v/v, as eluent).  
 
Reactions of hydroxamic acids with 1,3-cyclohexadiene 
Entry 1, Table 1: Phenyl-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate 14 
A) The reaction was performed according to GP1, using phenyl hydroxycarbamate 1 (128 mg, 0.83 
mmol), 1,3-cyclohexadiene (134 mg, 1.68 mmol), and sodium periodate (179 mg, 0.83 mmol). The 
reaction mixture was stirred for 2 h. The product 14 was obtained as a white solid (99 mg, 51 %); m.p. 
127–129 °C; 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.28 (m, 2H), 7.21 – 7.15 (m, 1H), 7.14 – 7.06 (m, 
2H), 6.73 – 6.64 (m, 1H), 6.63 – 6.57 (m, 1H), 4.99 – 4.90 (m, 1H), 4.88 – 4.80 (m, 1H), 2.31 – 2.17 (m, 
2H), 1.59 – 1.52 (m, 1H), 1.48 – 1.40 (m, 1H); 13C{1H} NMR (101 MHz, CDCl3) δ 155.9, 150.9, 132.0, 
131.8, 129.3, 125.6, 121.5, 71.4, 50.3, 23.4, 20.7; FTIR (thin film) inter alia 1716 (C=O), 1389, 1196, 
1067, 994, 750, 691 cm-1; LRMS (ESI+) m/z 254.2 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H13N-
O3Na 254.0793 found 254.0800. 
B) The reaction was performed according to GP2 using phenyl hydroxycarbamate 1 (103 mg, 0.67 
mmol), 1,3-cyclohexadiene (66 mg, 0.80 mmol), CuCl2 (9 mg, 0.07 mmol) and 2-ethyl-2-oxazoline (13 
mg, 0.13 mmol), the reaction was complete in 2 h giving 14 (152 mg, 98 %) as a white solid. 
 
Entry 2, Table 1: N-Phenyl-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 15 
A) The reaction was performed according to GP1, using 1-hydroxy-3-phenylurea 2 (131 mg, 0.86 
mmol), 1,3-cyclohexadiene (138 mg, 1.72 mmol), and sodium periodate (184 mg, 0.86 mmol). The 
reaction mixture was stirred for 2 h. The product 15 was obtained as a white solid (97 mg, 49%); m.p. 
102 – 104 °C; 1H NMR (400 MHz, CDCl3) δ 7.63 (s, 1H), 7.44 (dd, J = 8.6, 1.0 Hz, 2H), 7.28 (dd, J = 
10.9, 5.4 Hz, 2H), 7.10 – 7.01 (m, 1H), 6.62 – 6.56 (m, 1H), 6.55 – 6.47 (m, 1H), 5.06 – 4.98 (m, 1H), 
4.83 – 4.75 (m, 1H), 2.25 – 2.13 (m, 2H), 1.61 – 1.53 (m, 1H), 1.43 – 1.36 (m, 1H); 13C{1H} NMR (101 
MHz, CDCl3) δ 159.3, 137.7, 132.7, 130.4, 128.9, 123.5, 119.3, 71.2, 50.0, 23.9, 20.0; FTIR (thin film) 
inter alia 1667 (C=O), 1594, 1531, 1445, 1228, 907, 767, 701 cm-1; LRMS (ESI+) m/z 253.2 (M+ + 
Na); HRMS (ESI+) m/z Calcd for C13H14N2O2Na 253.0953 found 253.0958. 
B) The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (105 mg, 0.69 
mmol), 1,3-cyclohexadiene (68 mg, 0.83 mmol), CuCl2 (9 mg, 0.07 mmol) and 2-ethyl-2-oxazoline (14 
mg, 0.14 mmol), the reaction complete in 4 h giving 15 (156 mg, 98%) as a white solid. 
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Entry 3, Table 1: N-[(R)-1-Phenylethyl]-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxamide 16 
A) The reaction was performed according to GP1, using (R)-1-hydroxy-3-(1-phenylethyl)urea 3 (125 
mg, 0.70 mmol), 1,3-cyclohexadiene (112 mg, 1.39 mmol), and sodium periodate (149 mg, 0.70 mmol). 
The reaction mixture was stirred for 2 h. The product 16 was obtained as a white solid (76 mg, 42%); 
m.p. 92-94 °C; 1H NMR (700 MHz, CDCl3) δ 7.33 – 7.22 (m, 3H), 7.22 – 7.17 (m, 2H), 6.54 – 6.40 (m, 
2H), 5.99 (dd, J = 22.7, 7.1 Hz, 1H), 4.96 – 4.84 (m, 2H), 4.64 (d, J = 2.1 Hz, 1H), 2.16 – 2.03 (m, 2H), 
1.52 – 1.45 (m, 1H), 1.41 (dd, J = 12.6, 6.9 Hz, 3H), 1.34 – 1.28 (m, 1H); 13C{1H} NMR (176 MHz, 
CDCl3) δ 161.5, 161.4, 143.7, 143.5, 132.2, 132.1, 130.2, 130.2, 128.5, 128.4, 127.1, 127.0, 126.0, 
125.9, 70.5, 50.3, 50.1, 49.1, 49.1, 23.9, 23.9, 22.4, 22.3, 20.1, 20.0. FTIR (thin film) inter alia 1651, 
1515, 1494, 1230, 906, 766, 699, 667 cm-1; LRMS (ESI+) m/z 281.2 (M+ + Na); HRMS (ESI+) m/z 
Calcd for C15H18N2O2Na 281.1266 found 281.1268. 
B) The reaction was performed according to GP2, using (R)-1-hydroxy-3-(1-phenylethyl)urea 3 (99 mg, 
0.55 mmol), 1,3-cyclohexadiene (53 mg, 0.66 mmol), CuCl2 (7 mg, 0.05 mmol) and 2-ethyl-2-oxazoline 
(11 mg, 0.11 mmol), the reaction was complete in 4 h giving 16 (141 mg,  97%) as a white solid. 
 
Entry 4, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-2-phenyl-ethanone 17 
A) The reaction was performed according to GP1, using N-hydroxy-2-phenylacetamide 4 (290 mg, 1.92 
mmol), 1,3-cyclohexadiene (307 mg, 3.84  mmol), and sodium periodate (410 mg, 1.92 mmol). The 
reaction mixture was stirred for 4 h. The product 17 was obtained as an off-white solid (275 mg, 48 %); 
m.p. 74 -76 °C; 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.19 (m, 5H), 6.66 – 6.56 (m, 1H), 6.50 – 6.42 
(m, 1H), 5.33 – 5.22 (m, 1H), 4.80 – 4.70 (m, 1H), 3.70 – 3.57 (m, 2H), 2.17 – 1.99 (m, 2H), 1.50 – 1.39 
(m, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 170.5, 134.8, 132.9, 131.3, 129.5, 128.2, 126.5, 71.9, 
46.6, 40.1, 23.4, 21.0; FTIR (thin film) inter alia 1640 (C=O), 1412, 1086, 955, 900, 828, 734, 698 cm-
1; LRMS (ESI+) m/z 252.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C14H15NO2 Na 252.1000  found 
252.1010. 
B) The reaction was performed according to GP3, using N-hydroxy-2-phenylacetamide 4 (208 mg, 1.38 
mmol), 1,3-cyclohexadiene (220 mg, 2.75  mmol), CuCl2 (19 mg, 0.14 mmol) and 2-ethyl-2-oxazoline 
(27 mg, 0.28 mmol), the reaction was heated at reflux and was complete in 10 h to yield the product as 
an off-white solid 16 (192 mg, 61 %). 
 
Entry 5, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-3-phenylpropan-1-one 18 
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A) The reaction was performed according to GP1, using N-hydroxy-3-phenylpropanamide 5 (171 mg, 
1.03 mmol), 1,3-cyclohexadiene (166 mg, 2.06 mmol), and sodium periodate (221 mg, 1.03 mmol). The 
reaction mixture was stirred for 4 h. The product 18 was obtained as colorless oil (123 mg, 49 %); 1H 
NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H), 7.24 – 7.18 (m, 3H), 6.69 – 6.59 (m, 1H), 6.53 – 6.48 
(m, 1H), 5.30 (s, 1H), 4.74 (s, 1H), 2.91 (t, J = 8.0 Hz, 2H), 2.70 – 2.62 (m, 1H), 2.59 – 2.51 (m, 1H), 
2.19 – 2.12 (m, 1H), 2.12 – 2.05 (m, 1H), 1.52 – 1.45 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 
171.1, 140.4, 132.0, 130.3, 127.4, 127.3, 124.9, 70.8, 45.4, 33.9, 29.3, 22.5, 20.1; FTIR (thin film) inter 
alia 1644 (C=O), 1453, 1166, 954, 902, 748, 699 cm-1; LRMS (ESI+) m/z 266.3 (M+ + Na); HRMS 
(ESI+) m/z Calcd for C15H17NO2 Na 266.1157 found 266.1169. 
B) The reaction was performed according to GP3, using N-hydroxy-3-phenylpropanamide 5 (189 mg, 
1.14 mmol), 1,3-cyclohexadiene (183 mg, 2.29 mmol), CuCl2 (15 mg, 0.11 mmol) and 2-ethyl-2-
oxazoline (23 mg, 0.23 mmol), the reaction was heated at reflux and was complete in 5 h. The product 
was obtained as colorless oil (181 mg, 65 %). 
 
Entry 6, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-4-phenylbutan-1-one 19 
A) The reaction was performed according to GP1, using N-hydroxy-4-phenylbutanamide 6 (153 mg, 
0.85 mmol), 1,3-cyclohexadiene (137 mg, 1.70 mmol), and sodium periodate (183 mg, 0.85 mmol). The 
reaction mixture was stirred for 4 h. The product 19 was obtained as colorless oil (70 mg, 32 %); 1H 
NMR (400 MHz, CDCl3) δ 7.24 – 7.16 (m, 2H), 7.14 – 7.06 (m, 3H), 6.55 (t, J = 6.6 Hz, 1H), 6.42 (t, J 
= 6.6 Hz, 1H), 5.20 (s, 1H), 4.66 (s, 1H), 2.60 – 2.51 (m, 2H), 2.31 – 2.17 (m, 2H), 2.13 – 1.94 (m, 2H), 
1.88 – 1.77 (m, 2H), 1.47 – 1.35 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 171.9, 141.0, 132.1, 
130.2, 127.5, 127.3, 124.8, 70.8, 45.4, 34.4, 31.7, 24.8, 22.6, 20.1; FTIR (thin film) inter alia 1644 
(C=O), 1453, 955, 902, 833, 746, 699 cm-1; LRMS (ESI+) m/z 280.3 (M+ + Na); HRMS (ESI+) m/z 
Calcd for C16H19NO2 Na 280.1313 found 280.1314. 
B) The reaction was performed according to GP3, using N-hydroxy-4-phenylbutanamide (200 mg, 1.12 
mmol), 1,3-cyclohexadiene (179 mg, 2.23 mmol), CuCl2 (15 mg, 0.11 mmol) and 2-ethyl-2-oxazoline 
(22 mg, 0.22 mmol), the reaction was heated at reflux and was complete in 3 h. The product was 
obtained as colorless oil (210 mg, 73 %) 
 
Entry 7, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-5-phenylpentan-1-one 20 
A) The reaction was performed according to GP1, using N-hydroxy-5-phenylpentanamide 7 (225 mg, 
1.16 mmol), 1,3-cyclohexadiene (187 mg, 2.32 mmol), and sodium periodate (249 mg, 1.16 mmol). The 
reaction mixture was stirred for 4 h. The product 20 was obtained as colorless oil (120 mg, 38 %); 1H 
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NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H), 7.21 – 7.17 (m, 3H), 6.63 (t, J = 6.7 Hz, 1H), 6.52 – 
6.47 (m, 1H), 5.29 (s, 1H), 4.75 (s, 1H), 2.63 (t, J = 7.2 Hz, 2H), 2.39 – 2.27 (m, 2H), 2.23 – 2.16 (m, 
1H), 2.12 – 2.07 (m, 1H), 1.68 – 1.60 (m, 4H), 1.53 – 1.47 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 
173.2, 142.5, 133.1, 131.2, 128.4, 128.2, 125.6, 71.7, 46.4, 35.7, 33.0, 31.1, 23.9, 23.6, 21.1; FTIR (thin 
film) inter alia 1648 (C=O), 1452, 1166, 956, 901, 834, 746, 698 cm-1; LRMS (ESI+) m/z 294.3 (M+ + 
Na); HRMS (ESI+) m/z Calcd for C17H21NO2 Na 294.1470 found 294.1468. 
B) The reaction was performed according to GP3, using N-hydroxy-5-phenylpentanamide 7 (176 mg, 
0.91 mmol), 1,3-cyclohexadiene (146 mg, 1.82 mmol), CuCl2 (12 mg, 0.09 mmol) and 2-ethyl-2-
oxazoline (18 mg, 0.18 mmol), the reaction was heated at reflux and was complete in 3 h. The product 
was obtained as colorless oil (193 mg, 78 %) 
 
Entry 8, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl(phenyl)methanone 21 
A) The reaction was performed according to GP1, using N-hydroxybenzamide 8 (594 mg, 4.33 mmol), 
1,3-cyclohexadiene (694 mg, 8.66 mmol), and sodium periodate (927 mg, 4.33 mmol). The reaction 
mixture was stirred for 4 h. The product 21 was obtained as an off-white solid (317 mg, 53%); m.p. 111 
– 114 °C; 1H NMR (400 MHz, CDCl3) δ 7.64 (s, 2H), 7.46 – 7.33 (m, 3H), 6.66 (br, 1H), 6.54 (s, 1H), 
5.38 (br, 1H), 4.79 (s, 1H), 2.36 – 2.18 (m, 2H), 1.58 – 1.45 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3) 
δ 168.9, 134.4, 132.8, 131.8, 130.7, 128.5, 128.0, 71.9, 47.4, 23.5, 21.2; FTIR (thin film) inter alia 1638 
(C=O), 929, 881, 788, 726, 703 cm-1; LRMS (ESI+) m/z 216.2 (M+ + H); HRMS (ESI+) m/z Calcd for 
C13H14NO2 216.1025 found 216.1037. 
B) The reaction was performed according to GP3, using N-hydroxybenzamide 8 (312 mg, 2.33 mmol), 
1,3-cyclohexadiene (373 mg, 4.65 mmol), CuCl2 (31 mg, 0.23 mmol) and 2-ethyl-2-oxazoline (46 mg, 
0.47 mmol), the reaction was heated at reflux and was complete in 20 h giving the product (245 mg, 
49%) as an off-white solid. 
Entry 9, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl(pyridin-2-yl)methanone  22 
The reaction was performed according to GP1, using 2-pyridinehydroxamic acid 9 (0.27 g, 2.0 
mmol),1,3-cyclohexadiene (0.31 mg, 3.9 mmol), and sodium periodate (0.42 g, 2.0 mmol). The reaction 
mixture was stirred for 4 h  to give a white solid product 22 (177 mg, 42%); m.p.  110 – 112 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.77 – 8.50 (m, 1H), 8.00 – 7.57 (m, 2H), 7.49 – 7.29 (m, 1H), 6.89 – 6.41 
(m, 2H), 5.66 – 5.37 (m, 1H), 5.06 – 4.67 (s, 1H), 2.50 – 2.18 (m, 2H), 1.67 – 1.40 (m, 2H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 162.1, 152.4, 148.1, 137.1, 132.0, 131.1, 125.2, 124.8, 71.8, 51.6, 23.4, 
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22.0; FTIR (thin film) inter alia 2933, 1632 (C=O), 1566, 954, 748, 710, 668 cm-1; LRMS (ESI+) m/z 
239.5 (M+ +Na); HRMS (ESI+) m/z Calcd for C12H12N2O2Na 239.0796 found 239.0814. 
 
Entry 10, Table 1: 2-Oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl(pyridin-3-yl)methanone 23 
The reaction was performed according to GP1, using 3-pyridinehydroxamic acid 10 (143 mg, 1.03 
mmol), 1,3-cyclohexadiene (166 mg, 2.06 mmol), and sodium periodate (221 mg, 1.03 mmol). The 
reaction mixture was stirred for 4 h. The product 23 was obtained as an off-white solid (69 mg, 31 %); 
m.p. 105 – 107 °C; 1H NMR (400 MHz, CDCl3) δ 8.92 (s, 1H), 8.64 (d, J = 3.4 Hz, 1H), 7.99 (s, 1H), 
7.30 (dd, J = 14.7, 7.8 Hz, 1H), 6.73 (s, 1H), 6.54 (s, 1H), 5.43 (s, 1H), 4.78 (s, 1H), 2.37 – 2.17 (m, 
2H), 1.56 (p, J = 11.2 Hz, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 166.1, 151.4, 150.1, 136.5, 133.3, 
131.7, 129.9, 122.7, 72.3, 47.1, 23.5, 20.9; FTIR (thin film) inter alia 1639 (C=O), 1586, 1387, 924, 
882, 824, 735, 699 cm-1; LRMS (ESI+) m/z 217.1 (M+ +H); HRMS (ESI+) m/z Calcd for C12H13N2O2 
217.0977 found 217.0993. 
 
Reactions of hydroxamic acids with 2,3-dimethyl-1,3-butadiene 
Entry 11, Table 1: Phenyl-4,5-dimethyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 24 
A) The reaction was performed according to GP1, using phenyl hydroxycarbamate 1 (133 mg, 0.87 
mmol), 2,3-dimethyl-1,3-butadiene (143 mg, 1.74 mmol), and sodium periodate (186 mg, 0.87 mmol). 
The product 24 was obtained as colorless oil (95.4 mg, 47%); 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.34 
(m, 2H), 7.24 – 7.19 (m, 1H), 7.19 – 7.13 (m, 2H), 4.34 (s, 2H), 4.09 (s, 2H), 1.73 – 1.69 (m, 3H), 1.66 
– 1.59 (m, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 153.6, 150.9, 129.3, 125.6, 123.2, 121.8, 121.6, 
72.0, 48.4, 15.2, 13.9; FTIR (thin film) inter alia 1720 (C=O), 1388, 1356, 1202, 1162, 1068, 755, 726, 
688 cm-1; LRMS (ESI+) m/z 256.2 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H15NO3Na 256.0950  
found 256.0955. 
B) The reaction was performed according to GP2, using phenyl hydroxycarbamate 1 (173 mg, 1.13 
mmol), 2,3-dimethyl-1,3-butadiene (111 mg, 1.36 mmol), CuCl2 (15 mg, 0.11 mmol) and 2-ethyl-2-
oxazoline (22 mg, 0.22 mmol), the reaction was stirred for 3 h giving 24 and 34 (250 mg, 95%) as a 
colorless oil. The ratio of 24:34 is 6:1. The ene product 34 could not be separated in a pure enough state 
to characterize it fully. 
 
Entry 12, Table 1: 4,5-Dimethyl-N-phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 25 
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A) The reaction was performed according to GP1, using 1-hydroxy-3-phenylurea 2 (138 mg, 0.91 
mmol), 2,3-dimethyl-1,3-butadiene (149 mg, 1.81 mmol), and sodium periodate (194 mg, 0.91 mmol). 
The product 25 was obtained as a white solid (95 mg, 45%); m.p. 99-102 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.66 (s, 1H), 7.46 (dd, J = 19.3, 8.2 Hz, 2H), 7.31 (t, J = 7.9 Hz, 2H), 7.06 (t, J = 7.4 Hz, 1H), 
4.29 (t, J = 9.9 Hz, 2H), 3.97 (t, J = 10.1 Hz, 2H), 1.78 – 1.68 (m, 3H), 1.63 – 1.61 (m, 3H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 155.5, 138.0, 129.0, 123.4, 122.6, 119.3, 119.3, 72.5, 47.7, 15.5, 13.7; FTIR 
(thin film) inter alia 1652 (C=O), 1594, 1527, 1446, 1435, 1221, 758, 731, 692 cm-1; LRMS (ESI+) m/z 
255.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H16N2O2Na 255.1109 found 255.1121. 
B) The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (186 mg, 1.22 
mmol), 2,3-dimethyl-1,3-butadiene (125 mg, 1.47 mmol), CuCl2 (16 mg, 0.12 mmol) and 2-ethyl-2-
oxazoline (24 mg, 0.24 mmol), the reaction was stirred for 6 h giving 25 and 35 (255 mg, 90 %) as a 
white solid. The ratio of 25:35 = 9:1. The ene product 35 could not be separated in a pure enough state 
to characterize it fully. 
 
Entry 13, Table 1: (R)-4,5-Dimethyl-N-(1-phenylethyl)-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 26 
A) The reaction was performed according to GP1, using (R)-1-hydroxy-3-(1-phenylethyl)urea (98 mg, 
0.54 mmol), 2,3-dimethyl-1,3-butadiene (89 mg, 1.09 mmol), and sodium periodate (116 mg, 0.54 
mmol). The product 26 was obtained as a colourless oil (18 mg, 13 %); 1H NMR (400 MHz, CDCl3) δ 
7.39 – 7.30 (m, 4H), 7.29 – 7.22 (m, 1H), 5.99 (d, J = 8.0 Hz, 1H), 5.07 – 4.98 (m, 1H), 4.25 – 4.15 (m, 
2H), 3.87 (dt, J = 19.8, 9.9 Hz, 2H), 1.71 – 1.64 (m, 3H), 1.61 – 1.56 (m, 3H), 1.52 (d, J = 6.9 Hz, 3H); 
13C{1H} NMR (101 MHz, CDCl3) δ 157.8, 143.9, 128.6, 128.6, 127.2, 126.1, 122.7, 122.6, 72.0, 49.2, 
48.2, 22.5, 15.5, 13.7; FTIR (thin film) inter alia 3308 (NH), 1652 (C=O), 1510, 1209, 1026, 762, 699 
cm-1; LRMS (ESI+) m/z 261.1 (M+ + H); HRMS (ESI+) m/z Calcd for C15H21N2O2  261.1603 found 
261.1619. 
B) The reaction was performed according to GP2, using (R)-1-hydroxy-3-(1-phenylethyl)urea 3 (64 mg, 
0.36 mmol), 2,3-dimethyl-1,3-butadiene (58 mg, 0.71 mmol), CuCl2 (5 mg, 0.04 mmol)  and 2-ethyl-2-
oxazoline (7 mg, 0.07 mmol), the resulting solution was stirred at room temperature in air. The reaction 
was complete in 6 h. The product 26 was obtained as a colorless oil (92 mg, 99%). 
Entry 14, Table 1:1-(4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)-2-phenylethanone 27 
The reaction was performed according to GP1, using N-hydroxy-2-phenylacetamide (164 mg, 1.09 
mmol), 2,3-dimethyl-1,3-butadiene (179 mg, 2.18 mmol), and sodium periodate (233 mg, 1.09 mmol). 
The product 27 was obtained as colorless oil (105 mg, 42 %); 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.26 
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(m, 4H), 7.26 – 7.21 (m, 1H), 4.03 (s, 4H), 3.79 (s, 2H), 1.66 (s, 3H), 1.59 – 1.51 (m, 3H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 169.9, 135.1, 129.3, 128.5, 126.7, 122.5, 121.8, 73.0, 45.2, 39.7, 15.3, 13.7; 
FTIR (thin film) inter alia 1652 (C=O), 1434, 1223, 711, 694 cm-1; LRMS (ESI+) m/z 254.3 (M+ + Na); 
HRMS (ESI+) m/z Calcd for C14H17NO2 Na 254.1157 found 254.1136. 
Entry 15, Table 1:1-(4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)-3-phenylpropan-1-one 28 
The reaction was performed according to GP1, using N-hydroxy-3-phenylpropanamide 5 (131 mg, 0.80 
mmol), 2,3-dimethyl-1,3-butadiene (131 mg, 1.59 mmol), and sodium periodate (170 mg, 0.80 mmol). 
The product 28 was obtained as colorless oil (72 mg, 37%); 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.26 
(m, 2H), 7.25 – 7.17 (m, 3H), 4.08 (s, 2H), 4.04 (s, 2H), 3.00 – 2.95 (m, 2H), 2.82 – 2.71 (m, 2H), 1.67 
(s, 3H), 1.58 – 1.54 (m, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 170.3, 140.44, 127.5, 127.5, 125.1, 
121.5, 121.0, 72.0, 44.0, 32.9, 29.8, 14.3, 12.8; FTIR (thin film) inter alia 1651 (C=O), 1440, 1212, 
750, 699 cm-1; LRMS (ESI+) m/z 268.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C15H19NO2 Na 
268.1313 found 268.1296. 
Entry 16, Table 1: 1-(4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)-4-phenylbutan-1-one 29 
The reaction was performed according to GP1, using N-hydroxy-4-phenylbutanamide (137 mg, 0.77 
mmol), 2,3-dimethyl-1,3-butadiene (126 mg, 1.54 mmol), and sodium periodate (164 mg, 0.77 mmol). 
The product 29 was obtained as colorless oil (80 mg, 40 %); 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 
(m, 2H), 7.23 – 7.16 (m, 3H), 4.16 (s, 2H), 4.02 (s, 2H), 2.72 – 2.66 (m, 2H), 2.47 (t, J = 7.5 Hz, 2H), 
2.03 – 1.95 (m, 2H), 1.68 (d, J = 0.8 Hz, 3H), 1.59 (d, J = 0.9 Hz, 3H); 13C{1H} NMR (101 MHz, 
CDCl3) δ 171.9, 141.8, 128.5, 128.3, 125.8, 122.5, 122.1, 72.9, 45.0, 35.4, 31.4, 26.1, 15.3, 13.8; FTIR 
(thin film) inter alia 1654 (C=O), 1439, 1216, 749, 699 cm-1; LRMS (ESI+) m/z 282.3 (M+ + Na); 
HRMS (ESI+) m/z Calcd for C16H21NO2 282.1470 Na found 282.1472. 
Entry 17, Table 1: 1-(4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)-5-phenylpentan-1-one 30 
The reaction was performed according to GP1, using N-hydroxy-5-phenylpentanamide (149 mg, 0.77 
mmol), 2,3-dimethyl-1,3-butadiene (126 mg, 1.54 mmol), and sodium periodate (164 mg, 0.77 mmol). 
The product 30 was obtained as colorless oil (86 mg, 41 %); 1H NMR (400 MHz, CDCl3) δ 7.29 – 7.24 
(m, 2H), 7.24 – 7.13 (m, 3H), 4.17 (s, 2H), 4.02 (s, 2H), 2.65 (t, J = 7.1 Hz, 2H), 2.46 (d, J = 6.4 Hz, 
2H), 1.73 – 1.64 (m, 7H), 1.59 (d, J = 0.9 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 172.1, 142.4, 
128.4,128.3, 125.7, 122.5,122.10, 72.9, 45.0, 35.7, 32.0, 31.2, 24.4, 15.3, 13.8; FTIR (thin film) inter 
alia 1655 (C=O), 1435, 1212, 748, 699 cm-1; LRMS (ESI+) m/z 296.3 (M+ + Na); HRMS (ESI+) m/z 
Calcd for C17H23NO2 Na 296.1626 found 296.1629 . 
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Entry 18, Table 1: (4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)(phenyl)methanone  31 
The reaction was performed according to GP1, using N-hydroxybenzamide 8 (152 mg, 1.14 mmol), 2,3-
dimethyl-1,3-butadiene (186 mg, 2.28 mmol), and sodium periodate (243 mg, 1.14 mmol). The product 
31 was obtained as a white solid (113 mg, 46 %); m.p. 62-64 °C; 1H NMR (400 MHz, CDCl3) δ 7.72 – 
7.65 (m, 2H), 7.49 – 7.44 (m, 1H), 7.43 – 7.38 (m, 2H), 4.18 (s, 2H), 4.14 (s, 2H), 1.71 (s, 3H), 1.59 
(dd, J = 1.8, 0.9 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 169.5, 133.8, 130.8, 128.5, 127.9, 122.7, 
121.9, 72.8, 46.6,15.4, 13.7; FTIR (thin film) inter alia 1640 (C=O), 1398, 1222, 1029, 796, 719, 696 
cm-1; LRMS (ESI+) m/z 240.2 (M+ + Na); HRMS (ESI+) m/z  Calcd for C13H15NO2 Na 240.1000 found 
240.0097.  
Entry 19, Table 1: (4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)(pyridin-2-yl)methanone 32 
The reaction was performed according to GP1, using 2-pyridinehydroxamic acid 9 (109 mg, 0.79 
mmol), 2,3-dimethyl-1,3-butadiene (130 mg, 1.58 mmol), and sodium periodate (169 g, 0.79 mmol). 
The reaction mixture was stirred for 4 h. The product 32 was obtained as an off-white solid (36 mg, 
21%); m.p. 85-87 °C; 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J = 4.5 Hz, 1H), 7.78 (td, J = 7.8, 1.4 Hz, 
1H), 7.61 (s, 1H), 7.38 – 7.33 (m, 1H), 4.24 (s, 4H), 1.70 (s, 3H), 1.60 (d, J = 0.8 Hz, 3H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 153.0, 148.8, 136.5, 124.8, 123.1, 121.3, 73.2, 45.5, 15.3, 13.8; FTIR (thin 
film) inter alia 1638, 1447, 1415, 1228, 1191, 1024, 993, 806, 748, 690 cm-1; LRMS (ESI+) m/z 219.3 
(M+ + H+); HRMS (ESI+) m/z Calcd for C12H15N2O2 219.1134 found 219.1150. 
Entry 20, Table 1: (4,5-Dimethyl-3,6-dihydro-2H-1,2-oxazin-2-yl)(pyridin-3-yl)methanone 33 
The reaction was performed according to GP1, using 3-pyridinehydroxamic acid 10 (152 mg, 1.10 
mmol), 2,3-dimethyl-1,3-butadiene (181 mg, 2.20 mmol), and sodium periodate (235 g, 1.10 mmol). 
The reaction mixture was stirred for 2 h. The product 33 was obtained as an off-white solid (43 mg, 
18%); m.p. 89-91 °C; 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 1.5 Hz, 1H), 8.68 (dd, J = 4.9, 1.7 Hz, 
1H), 8.03 (dt, J = 7.9, 1.9 Hz, 1H), 7.36 (ddd, J = 7.9, 4.9, 0.9 Hz, 1H), 4.20 (s, 2H), 4.13 (s, 2H), 1.73 
(d, J = 0.8 Hz, 3H), 1.59 (dd, J = 1.8, 0.9 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 166.9, 151.5, 
149.6, 136.4, 129.5, 123.0, 122.5, 121.7, 73.0, 46.1, 15.4, 13.7; FTIR (thin film) inter alia 1640, 1415, 
1230, 1021, 826, 729, 697 cm-1; LRMS (ESI+) m/z 241.1 (M+ + Na); HRMS (ESI+) m/z Calcd for 
C12H14N2O2Na  241.0953 found 241.0964. 
Reactions of 1 with other dienes 
Entry 1, Table 2: Phenyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 36 
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The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (162 mg, 1.06 
mmol), freshly cracked cyclopentadiene (84 mg, 1.27 mmol), CuCl2 (14 mg, 0.11 mmol) and 2-ethyl-2-
oxazoline (21 mg, 0.21 mmol), the reaction was stirred for 2 h giving 36 (228 mg, 99%) as a white 
solid; m.p. 113–114 °C; 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.33 (m, 2H), 7.24 – 7.19 (m, 1H), 7.14 – 
7.08 (m, 2H), 6.61 (dt, J = 5.5, 1.9 Hz, 1H), 6.52 – 6.47 (m, 1H), 5.35 (d, J = 1.4 Hz, 1H), 5.21 (s, 1H), 
2.12 (dt, J = 8.8, 1.9 Hz, 1H), 1.86 (d, J = 8.8 Hz, 1H); 13C{1H} NMR (101 MHz, CDCl3) δ 156.4, 
149.7, 133.6, 132.4, 128.4, 124.8, 120.4, 83.3, 64.4, 47.4; FTIR (thin film) inter alia 1749 (C=O), 1587, 
1489, 1332, 1271, 1192, 1181, 770, 746, 691 cm-1; LRMS (ESI+) m/z 240.2 (M+ + Na); HRMS (ESI+) 
m/z Calcd for C12H11NO3Na 240.0637  found 240.0650. 
 
Entry 2, Table 2:   (9S,10S)-Phenyl-9,10-dimethyl-9,10-dihydro-9,10-(epoxy-imino)-anthracene-11-
carboxylate 37 
The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (39 mg, 0.25 
mmol), 9,10-dimethylanthracene (47 mg, 0.23 mmol), CuCl2 (3 mg, 0.03 mmol) and 2-ethyl-2-
oxazoline (5 mg, 0.05 mmol), the reaction was stirred for 24 h giving 37 (70 mg, 80%) as a colorless 
oil; 1H NMR (400 MHz, CDCl3) δ 7.57 – 7.52 (m, 2H), 7.49 – 7.45 (m, 2H), 7.38 – 7.32 (m, 4H), 7.29 – 
7.25 (m, 2H), 7.17 – 7.14 (m, 1H), 6.78 – 6.69 (m, 2H), 2.67 (d, J = 13.8 Hz, 3H), 2.34 (s, 3H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 158.1, 150.8, 141.6, 140.4, 129.2, 127.4, 125.6, 121.6, 121.6, 120.8, 79.7, 
64.5, 16.4, 15.0; FTIR (thin film) inter alia 1725 (C=O), 1274, 1229, 1194, 1016, 741, 688 cm-1; LRMS 
(ESI+) m/z 380.2 (M+ + Na); HRMS (ESI+) m/z C23H19NO3Na 380.1263 found 380.1257. 
 
Entry 3, Table 2: Phenyl-3,6-dimethyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 38 
The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (131 mg, 0.86 
mmol), 2,4-hexadiene (84 mg, 1.03 mmol), CuCl2 (12 mg, 0.09 mmol) and 2-ethyl-2-oxazoline (17 mg, 
0.17 mmol), the reaction was stirred for 3 h giving 38 (185 mg, 93%) as a colorless oil; 1H NMR (400 
MHz, CDCl3) δ 7.39 – 7.35 (m, 2H), 7.22 (dd, J = 10.6, 4.3 Hz, 1H), 7.18 – 7.14 (m, 2H), 5.84 (ddd, J = 
10.2, 4.3, 2.1 Hz, 1H), 5.79 – 5.71 (m, 1H), 4.85 – 4.73 (m, 1H), 4.64 – 4.57 (m, 1H), 1.42 (d, J = 6.7 
Hz, 3H), 1.33 (d, J = 6.7 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 152.8, 150.8, 129.2, 128.6, 
127.5, 125.4, 121.5, 74.3, 50.2, 18.7, 18.1; FTIR (thin film) inter alia 1715 (C=O), 1366, 1189, 1037, 
748, 725, 689 cm-1; LRMS (ESI+) m/z 256.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H15NO3Na 
256.0950 found 256.0926. 
 
Entry 4, Table 2:  Phenyl-3,6-diphenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 39 
	   36	  
The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (92 mg, 0.60 
mmol), 1,4-diphenyl-1,3-butadiene (111 mg, 0.54 mmol), CuCl2 (8 mg, 0.06 mmol) and 2-ethyl-2-
oxazoline (12 mg, 0.12 mmol), the reaction was stirred for 24 h giving 39 as a white solid (172 mg, 
82%); m.p. 144 – 147 °C; 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.57 (m, 2H), 7.50 – 7.46 (m, 2H), 7.44 
– 7.34 (m, 8H), 7.24 – 7.20 (m, 1H), 7.15 (d, J = 7.6 Hz, 2H), 6.25 – 6.15 (m, 2H), 5.81 – 5.73 (m, 2H); 
13C{1H} NMR (101 MHz, CDCl3) δ 188.5, 153.1, 150.9, 138.4, 136.8, 129.3, 129.2, 128.8, 128.7, 
128.2, 128.1, 127.9, 125.9, 125.7, 121.7, 80.3, 77.2; FTIR (thin film) inter alia 1716 (C=O), 1360, 
1272, 1194, 868, 747, 726, 689 cm-1; LRMS (ESI+) m/z 380.2 (M+ + Na); HRMS (ESI+) m/z Calcd for 
C23H19NO3Na 380.1263  found 380.1227.  
 
Entry 5, Table 2:  Phenyl-6-(hydroxymethyl)-3-methyl-3,6-dihydro-2H-1,2-oxa-zine-2-carboxylate 40 
and phenyl 3-(hydroxymethyl)-6-methyl-3,6-dihydro-2H-1,2-oxazine -2-carboxylate  41 
The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (140 mg, 0.91 
mmol), 2,4-hexadiene-1-ol (90 mg, 0.91mmol), CuCl2 (12 mg, 0.09 mmol) and 2-ethyl-2-oxazoline (18 
mg, 0.18 mmol), the reaction was stirred for 3 h giving 40 and 41 (210 mg, 93 %) as a yellow oil. The 
ratio of 40:41 is 1:1;  
40: 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.34 (m, 2H), 7.28 – 7.21 (m, 1H), 7.21 – 7.11 (m, 2H), 6.06 – 
6.02 (m, 1H) , 5.87 – 5.83 (m, 1H) , 4.63 – 4.56 (m, 1H), 4.55 – 4.45 (m, 2H), 4.11 (dd, J = 7.2, 2.3 Hz, 
1H), 1.94 (s, 1H), 1.53 (d, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 153.1, 150.8, 131.26, 
129.4, 125.7, 123.0, 121.6, 75.89, 65.6, 63.52, 50.5, 21.0 
41: 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.34 (m, 2H), 7.28 – 7.21 (m, 1H), 7.21 – 7.11 (m, 2H) , 6.02 
– 5.97 (m, 1H), 5.79 (dt, J = 10.3, 1.5 Hz, 1H) , 4.86 – 4.80 (m, 1H) , 4.71 – 4.63 (m, 1H) , 3.86 (dd, J = 
12.5, 3.0 Hz, 1H), 3.75 (dd, J = 12.4, 6.3 Hz, 1H), 2.45 (br, 1H), 1.45 (d, J = 6.7 Hz, 3H); 13C{1H} 
NMR (101 MHz, CDCl3) δ 153.1, 150.8, 130.1, 129.4, 125.7, 123.8, 121.6, 79.3, 63.6, 50.8, 18.3; FTIR 
(thin film) inter alia 1715 (C=O), 1369, 1312, 1188, 1164, 1065, 749, 689 cm-1; LRMS (ESI+) m/z 
272.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H15NO4Na 272.0899 found 272.0907.  
 
Entry 6, Table 2:  Phenyl-4-methyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 42 and phenyl-5-
methyl-3,6-dihydro-2H-1,2-oxazine-2-carboxylate 43 
The reaction was performed according to GP2, using crude phenyl hydroxycarbamate 1 (142 mg, 0.93 
mmol), isoprene (70 mg, 1.11 mmol), CuCl2 (12 mg, 0.09 mmol) and 2-ethyl-2-oxazoline (18 mg, 0.18 
mmol), the reaction was stirred for 3.5 h giving 42, 43 and 44 (183 mg, 90 %) as a colorless oil. The 
ratio of 42 and 43:44 is 3:1 and the ratio of 42:43 is 1.79:1;  
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42: 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.35 (m, 2H), 7.25 – 7.20 (m, 1H), 7.19 – 7.14 (m, 2H), 5.64 – 
5.60 (m, 1H), 4.54 – 4.47 (m, 2H), 4.18 – 4.09 (m, 2H), 1.81 – 1.75 (m, 3H); 13C{1H} NMR (101 MHz, 
CDCl3) δ 150.8, 129.4, 125.7, 121.6, 121.6, 118.0, 116.2, 68.9, 48.5, 19.9. 
43: 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.34 (m, 2H), 7.25 – 7.19 (m, 1H), 7.19 – 7.13 (m, 2H), 5.60 – 
5.57 (m, 1H), 4.42 – 4.37 (m, 2H), 4.26 – 4.20 (m, 2H), 1.74 – 1.70 (m, 3H); 13C{1H} NMR (101 MHz, 
CDCl3) δ 153.6, 131.6, 130.1, 125.7, 121.6, 118.0, 115.3, 72.0, 44.8, 18.3; FTIR (thin film) inter alia 
1717 (C=O), 1383, 1200, 1163, 1070, 752, 688 cm-1; LRMS (ESI+) m/z 242.2 (M+ + Na); HRMS 
(ESI+) m/z Calcd for C12H13NO3Na 242.0793 found 242.0771. 
 
Reactions of 2 with other dienes 
Entry 7, Table 2:  N-Phenyl-2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxamide 45 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (182 mg, 1.20 mmol), 
freshly cracked cyclopentadiene (95 mg, 1.44 mmol), CuCl2 (16 mg, 0.12 mmol) and 2-ethyl-2-
oxazoline (24 mg, 0.24 mmol), the reaction was stirred for 4 h giving 45 (249 mg, 96 %) as a white 
solid; m.p. 108-112 °C; 1H NMR (400 MHz, CDCl3) δ 7.48 (t, J = 16.2 Hz, 1H), 7.42 (dt, J = 8.7, 1.7 
Hz, 2H), 7.31 – 7.26 (m, 2H), 7.08 – 7.03 (m, 1H), 6.52 (dt, J = 5.5, 1.9 Hz, 1H), 6.39 (ddd, J = 5.6, 2.3, 
1.6 Hz, 1H), 2.08 (dt, J = 8.8, 1.9 Hz, 1H), 1.83 (d, J = 8.8 Hz, 1H); 13C{1H} NMR (101 MHz, CDCl3) 
δ 159.7, 137.4, 135.6, 132.0, 129.0, 123.8, 119.3, 84.4, 65.2, 48.7. FTIR (thin film) inter alia 1660 
(C=O), 1596, 1522, 1448, 1338, 753, 690 cm-1; LRMS (ESI+) m/z 270.2 (M+ + Na); HRMS (ESI+) m/z 
Calcd for C12H12N2O2Na 239.0796 found 239.0782. 
 
Entry 8, Table 2: (9S,10S)-Phenyl-9,10-dimethyl-9,10-dihydro-9,10-(epoxy-imino)-anthracene-11-
carboxamide 46 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (37 mg, 0.24 mmol), 
9,10-dimethylanthracene (45 mg, 0.22 mmol), CuCl2 (3 mg, 0.02 mmol) and 2-ethyl-2-oxazoline (5 mg, 
0.05 mmol), the reaction was stirred for 48 h giving 46 (9 mg, 10%) which decomposes to 9,10-
dimethylanthracene and the nitroso species in solution at room temperature. 
 
Entry 9, Table 2: 3,6-Dimethyl-N-phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 47 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (120 mg, 0.79 mmol), 
2,4-hexadiene (78 mg, 0.95 mmol), CuCl2 (11 mg, 0.08 mmol) and 2-ethyl-2-oxazoline (16 mg, 0.16 
mmol). The reaction was stirred for 4 h giving 47 (177 mg, 97%) as colorless oil; 1H NMR (400 MHz, 
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CDCl3) δ 7.60 (s, 1H), 7.49 (d, J = 8.6, 2H), 7.34 – 7.27 (m, 3H), 7.09 – 7.02 (m, 2H), 5.91 – 5.85 (m, 
1H), 5.75 – 5.67 (m, 1H), 4.74 – 4.59 (m, 2H), 1.34 (d, J = 6.7 Hz, 3H), 1.30 (d, J = 6.7 Hz, 3H); 
13C{1H} NMR (101 MHz, CDCl3) δ 154.4, 138.1, 128.9, 128.6, 128.1, 123.2, 119.3, 75.2, 49.0, 19.0, 
16.9; FTIR (thin film) inter alia 1669 (C=O), 1649, 1594, 1522, 1444, 1231, 751, 727, 692  cm-1; 
LRMS (ESI+) m/z 233.2 (M+ + H); HRMS (ESI+) m/z Calcd for C13H17N2O2 233.1290  found 
233.1315. 
 
Entry 10, Table 2: N-3,6-Triphenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 48 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (79 mg, 0.52 mmol), 
1,4-diphenyl-1,3-butadiene (96 mg, 0.47 mmol), CuCl2 (7 mg, 0.05 mmol) and 2-ethyl-2-oxazoline (10 
mg, 0.10 mmol), the reaction was stirred for 48 h 48 (50 mg, 30 %) as colorless oil which slowly 
decomposed to 1,4-diphenyl-1,3-butadiene and presumably nitroso species during purification; 1H NMR 
(400 MHz, CDCl3) δ 7.64 – 7.58 (m, 3H), 7.55 – 7.49 (m, 4H), 7.34 – 7.31 (m, 4H), 7.14 – 7.02 (m, 
4H), 6.72 (s, 1H), 6.29 – 6.18 (m, 1H), 6.15 – 6.08 (m, 1H), 5.92 – 5.83 (m, 1H), 5.74 – 5.67 (m, 1H); 
13C{1H} NMR (101 MHz, CDCl3) δ 153.8, 138.5, 137.9, 136.9, 129.5, 129.0, 128.9, 128.5, 128.3, 
128.1, 128.0, 127.5, 126.9, 123.4, 119.4, 81.3, 55.7; FTIR (thin film) inter alia 1710 (C=O), 1599, 
1526, 1500, 1446, 1314,1225, 1068, 752, 723, 691 cm-1; LRMS (ESI+) m/z 379.3 (M+ + Na); HRMS 
(ESI+) m/z Calcd for C23H20N2O2Na 379.1422 found 379.1428. 
 
Entry 11, Table 2: 6-(Hydroxymethyl)-3-methyl-N-phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 
49 and 3-(hydroxymethyl)-6-methyl-N-phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 50 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (70 mg, 0.46 mmol), 
2,4-hexadien-1-ol (45 mg, 0.46 mmol), CuCl2 (7 mg, 0.05 mmol) and 2-ethyl-2-oxazoline (9 mg, 0.09 
mmol). The reaction was stirred for 3 h giving 49 and 50 (103 mg, 90%) as colorless oil. The ratio of 
49:50 is 1.5:1;  
49: 1H NMR (400 MHz, CDCl3) δ 7.88 (s, 1H), 7.52 – 7.43 (m, 2H), 7.36 – 7.29 (m, 2H), 7.13 – 7.03 
(m, 1H), 6.02 (ddd, J = 10.2, 4.6, 2.3 Hz, 1H),  5.66 (dt, J = 10.2, 1.5 Hz, 1H), 4.70 (ddd, J = 11.0, 5.5, 
3.4 Hz, 2H), , 3.89 – 3.82 (m, 2H), 2.42 (br, 1H), , 1.26 (d, J = 6.6 Hz, 3H); 13C{1H} NMR (151 MHz, 
CDCl3) δ 154.6, 137.6, 130.4 (ene), 129.0, 123.7, 123.2(ene), 119.7, 74.5, 63.8, 54.6, 18.9;  
50: 1H NMR (400 MHz, CDCl3) δ 7.67 (s, 1H), 7.44 (d, J = 8.0 Hz, 2H), 7.28 (t, J = 7.7 Hz, 2H), 7.05 
(t, J = 7.4 Hz, 1H), 5.85 (d, J = 10.6 Hz, 1H), 5.80 (d, J = 10.3 Hz, 1H), 4.78 (s, 1H), 4.67 (dd, J = 12.6, 
6.2 Hz, 1H), 3.84 (s, 1H), 3.76 (s, 1H), 3.18 (s, 1H), 1.31 (d, J = 6.7 Hz, 3H); 13C{1H} NMR (151 MHz, 
CDCl3) δ 155.1, 138.0, 131.3 (ene), 128.9, 123.4, 122.9 (ene), 119.6, 80.0, 63.7, 49.3, 17.0; FTIR (thin 
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film) inter alia 1707 (C=O), 1600, 1534, 1501, 1446, 1314, 1224, 1067, 753, 724, 691 cm-1; LRMS 
(ESI+) m/z 271.2 (M+ + Na); HRMS (ESI+) m/z Calcd for C13H16N2O3Na 271.1083 found 271.1069.  
 
Entry 12, Table 2: 4-Methyl-N-phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 51 and 5-methyl-N-
phenyl-3,6-dihydro-2H-1,2-oxazine-2-carboxamide 52 
The reaction was performed according to GP2, using 1-hydroxy-3-phenylurea 2 (140 mg, 0.92 mmol), 
isoprene (75 mg, 1.10 mmol), CuCl2 (12 mg, 0.092 mmol) and 2-ethyl-2-oxazoline (18 mg, 0.18 mmol), 
the reaction was stirred for 6 h giving 51, 52 and 53 (191 mg, 95%) as a white solid. After purification 
by silica gel chromatography, the cycloadducts were separated from the ene-product. However, the 
separation of the two cycloadducts was not possible due to their similar Rf values. The ene product 53 
could not be separated in a pure enough state to characterize it fully. The ratio of 51:52 is 4.45:1 and the 
ratio of 51 and 52:53 is 9:1; m.p. 69 – 72 °C;  
51: 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.48 (dt, J = 8.8, 1.7 Hz, 2H), 7.31 (tq, J = 5.8, 1.9 Hz, 
2H), 7.11 – 7.02 (m, 1H), 5.55 (ddt, J = 4.5, 3.0, 1.6 Hz, 1H), 4.47 (dp, J = 4.3, 2.1 Hz, 2H), 4.02 (d, J = 
0.8 Hz, 2H), 1.82 – 1.77 (m, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 155.5, 138.0, 131.0, 129.0, 
123.4, 119.3, 117.5, 69.4, 47.8, 19.9. 
52: 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.48 (dt, J = 8.8, 1.7 Hz, 2H), 7.31 (tq, J = 5.8, 1.9 Hz, 
2H), 7.10 – 7.03 (m, 1H), 5.61 (dd, J = 3.3, 1.7 Hz, 1H), 4.36 (d, J = 0.7 Hz, 2H), 4.10 (dd, J = 3.4, 2.1 
Hz, 2H), 1.71 (d, J = 1.5 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 155.6, 137.9, 131.1, 129.0, 
123.4, 119.3, 117.0, 72.5, 44.0, 18.2; FTIR (thin film) inter alia 1644 (C=O), 1593, 1514, 1447, 1215, 
751, 725, 689  cm-1; LRMS (ESI+) m/z 241.3 (M+ + Na); HRMS (ESI+) m/z Calcd for C12H14N2O2Na 
241.0953 found 241.0940. 
 
X-Ray Crystallography 
X-ray diffraction experiments were carried out on a Bruker 3-circle diffractometer with a SMART 6000 
CCD area detector, using graphite-monochromated Mo-Kα radiation ( =0.71073 Å) and a Cryostream 
(Oxford Cryosystems) open-flow N2 cryostat. The structures (see Figs. S46, S47 and S48) were solved 
by direct methods and refined by full-matrix least squares, using OLEX243 and SHELXL44 (multiple-
CPU version 2013/2) software. Compound 9 was studied as a monohydrate; the crystal was a 2-
component [0.596(2):0.404(2)] non-merohedral twin; the data were deconvoluted using the TWINABS 
program.45 In molecule 17, the bicyclic system is disordered (in a 55:45 ratio) between two orientations 
differing by a ca 20° rotation around the C(2)…C(5) axis. Molecule 14 lies astride a crystallographic 
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mirror plane which passes through C(1), C(2), C(5), O(1), O(2), C(8) and C(11), thus the bicyclic 
system is disordered equally between two orientations related via this plane. The asymmetric units of 2, 
3 and 16 each comprise two independent molecules, with similar conformations in 2 and substantially 
different ones in 3 and 16. The absolute configurations of 3 and 16 could not be determined by X-ray 
methods (due to the small anomalous scattering) and were assigned according to the chirality of the 
parent compounds. Selected crystal data are listed in Table S1, full structural information has been 
deposited at Cambridge Structural Database, CCDC 984694 to 984704. 
 
Computations 
All computations were carried out with the Gaussian 09 package.46  The geometries in this study were 
optimized at the B3LYP/6-31G* level47 with no symmetry constraints and also at the B3LYP/6-
311++G** level for 14, 15 and 21. Diradicals were examined at the unrestricted B3LYP/6-31G* level 
using the GUESS=(MIX,ALWAYS) command. Unless otherwise indicated, the energies quoted are 
electronic energies without zero point and thermal energy modifications. The optimized geometries 
were found to be true minima based on no imaginary frequencies obtained from frequency calculations. 
The transition-state (TS) geometries were located using the OPT=QST3 keyword method. Frequency 
calculations on TS geometries revealed each TS geometry to contain one imaginary frequency. All 
intrinstic reaction pathways shown in Figures 4, 6, 7 and 8 were determined from transition state 
geometries using the IRC command. Animations (http://community.dur.ac.uk/m.a.fox/Chaiyaveij.ppt) 
of reaction pathways were generated from the GaussView 4.1 software48 and modified with the 
EasyGIF program.49 Calculated 11B and 13C NMR chemical shifts obtained at the GIAO50-B3LYP/6-
31G*//B3LYP/6-31G* level on the optimized geometries were referenced to TMS for 1H: δ (1H) = 
1.02[32.5 - σ(1H)] and for 13C: δ (13C) = 1.08[184.5 - σ(13C)]. 
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